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Abstract
Gelatine, which is produced by collagen partial hydrolysis, has been largely
used in the biomedical field for a wide variety of applications, which are rang-
ing from drug delivery to wound healing. Its spread depends strongly on its
biocompatibility: this natural polymer is indeed non-toxic, non-carcinogenic,
non-immunogenic, enzymatically degradable and bioresorbable. In the biomed-
ical field gelatine is mostly used as highly concentrated hydrogel (with a melting
point above 43 °C - 45 °C) or cross-linked.
This work investigated the use of uncross-linked gelatine hydrogels, with a
melting temperature in the physiological range, for different biomedical appli-
cations.
Firstly, it was studied the possibility to produce a solid hydrogel to use as
easily removable wound dressing. Once applied to a wound, this patch keeps a
moist environment in order to improve the regeneration, while releasing drugs
or bioactive factors that it could be preloaded of. Moreover, it can be easily
removed, without damages to the wound site and the newly formed tissue, by
washing with warm sterile water (37 °C - 39 °C).
Secondly, the gelatine material was investigated as substrate for the so-
named cell sheet engineering. With our procedure cell sheets can be grown
on the gelatine gel and, successively, they can be integrally transferred to a
different surface, with gelatine being removed by melting at 37 °C, without any
proteolytic enzyme. The gelatine sheet supporting cells, differently from the
“Okano” cell sheet method, could be also directly implanted in-vivo without
13
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any need for removal, due to the gentle melting of the gelatine sheet after
implantation.
Thirdly, gelatine gels were used as depot to release pro-angiogenic factors
in-vivo. Due to their ability to absorb aqueous solutions and release them while
dissolving / degrading, gelatine gels were loaded with Amniotic Fluid Stem
Cells Conditioned Medium and used to evaluate the effect of grow factors in a
model of ischemic fasciocutaneous flap.
Additionally, in order to evaluate the in-vivo degradation rate of gelatine
gels loaded with Platelet Rich Plasma, a preliminary test was performed. The
results of this test suggested the possibility to employ the gel films as antiad-
hesive membranes in surgery.
Since the gelatine hydrogels ability to melt at body temperature is still
almost completely unexploited in the medical field, the work described in this
thesis was protected by two patent deposits: EP 11 183 232 “Therapeutic use
of gelatin hydrogels with a gel-sol transition at body temperature” and EP 11
183 233 “Medical uses of lyophilized polymeric membranes containing blood
derivatives”.
Chapter 1
Introduction
1.1 Tissue Engineering
Important results in terms of healing and reconstruction of human tissue have
been achieved by extensive research in the medical and engineering fields with a
world wide biomaterials market that in 2005 was worth more than 300 billions
dollars, with a grow rate of 20% per year.
Tissue engineering and regenerative medicine focuses on the production of
new materials and devices able to interact with cells and biological tissue to
promote regeneration. Several definitions of Tissue Engineering were given in
the past, such as from Langer et al. They defined Tissue Engineering as “an
interdisciplinary field that applies the principles of engineering and life sciences
toward the development of biological substitutes that restore, maintain, or
improve tissue function” [1]. Tissue engineering approaches the problem with
the production of scaffolds, which are often preloaded with cells and designed
to mimic natural tissue structure and function. On the other hand regenerative
medicine usually focuses more on the use of stem cells for the production of
new tissue [2].
In the last few years tissue engineering has became a viable option for
tissue and organ function replacement thanks to the progress in the field. The
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creation of these complex devices, often loaded with cells, requires a three
dimensional, porous, biocompatible scaffold. The main role of scaffolds is the
promotion of new tissue formation while acting as temporary support for the
new forming tissue.
Scaffolds should also preferably be biodegradable and their degradation
products should be biocompatible, in order to avoid chronic inflammatory re-
sponse. Geometry, porosity and chemistry of the device have to allow suffi-
cient permeability, necessary for nutrients exchange, and to avoid stagnation
of wastes.
By changing materials and/or fabrication method, scaffold properties can
be adapted to the different physical or biological requirements, such as strength,
porosity, degradation rate, and surface chemistry. As already said, in most
cases scaffolds should be biodegradable, with degradation by-products which,
as the native polymers, possess the required biocompatibility with the host
tissue [3, 1]. Moreover, in most cases scaffold materials are polymers which
can be synthetic or natural.
Synthetic polymers The technology for the production of synthetic poly-
mers offers the possibility to tailor their chemical structure, and therefore their
properties on specific needs. Another advantage derives from their degrada-
tion mechanism, mostly hydrolytic, hence with a reproducible degradation
rate independent of the host. On the other hand, some of them, which are
degraded by acid hydrolysis, produce acids as degradation products, leading
to an auto-catalytic degradation process, especially in thick samples; the acidic
environment induced by degradation may result in inflammatory response or
fibrous encapsulation [4, 5, 6].
Most of synthetic polymers used in tissue engineering are polyesters (poly
(glycolic) acid [7] , poly (L-lactic) acid [8], poly(D,L-lactic acid-co-glycolic
acid [9], poly(ε-caprolattone, poly(propylene fumarate), polyorthoester) [10],
but there are also polyanhydrides [11], polycarbonates, poly(ethylene glycol)
and poly(ethylene oxide) [12].
1.1. TISSUE ENGINEERING 17
Natural polymers Most of natural polymers are enzymatically biodegrada-
ble; they often contain biofunctional moieties, which are known to improve cell
adhesion, proliferation and differentiation. Even if these properties could ap-
pear all positive, some of them may be a problem for the production of scaffolds.
In particular enzymatic biodegradability can lead to precocious degradation or
to a biostable material, depending on the enzyme levels and activity, which
are not constant in the body and can be much different from one patient to
another. For this reason the degradation rate could become difficult to predict
and tailor.
Natural polymers are further divided into two major classes: polypep-
tides and polysaccharides. Most known polypeptides are collagen [13], gelatine
(which is basically denaturated collagen), elastin [14] and fibrin [15] (mainly
obtained by mammalian and fishes), and silk [16] (obtained by insects and
arachnids). Collagen is one of the most important component of mammalians
tissues, therefore it is easy to understand why it is one of the most studied
materials in tissue engineering. On the other hand, the most used polysac-
charides are agarose and alginate [17] (derived from algae), chitosan [18] (ob-
tained by partial deacetylation of chitin, found in crustacean and insect ex-
oskeleton), starch [19] (extracted from vegetables), and hyaluronic acid [20] (a
glycosaminoglycan (GAG), found in mammalians extracellular matrix).
Biocompatibility and inflammation response The biological response
to any living tissue damage is inflammation. Since scaffolds, prosthesis or
any other device implantation in the body will cause some kind of injury to
the surrounding tissues, inflammation will certainly occur [21]. Moreover, any
implant represents a “foreign body” for the host, which causes an amplified
inflammatory response [22]. The aim of this response is the protection of the
organism, by destroying or isolating the foreign body; to achieve this goal, a
series of complex events takes place.
In the first instance, acute inflammation occurs. This cleans the wound
site, and provides a provisional matrix. This phase is characterized by vessels
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dilation in order to increase the blood flow to the area. Fibrin contained in
the blood coagulates and forms a clot, which closes the wound, preventing
successive contaminations. Many proteins, such as cytokines and growth fac-
tors, are released in the area, while cells, mainly neutrophils and monocytes,
are recruited to the injury site [23]. If the foreign body is not eliminated by
neutrophils and macrophages, it leads to chronic inflammation [24].
In case of chronic inflammation monocytes, macrophages as well as lym-
phocytes are still present, new blood vessels are formed to ensure an adequate
transport of nutrients, and an increase in the production of connective tissue
is observed. In this phase the fibrin cloth previously formed is transformed
in highly vascularized granulation tissue by fibroblasts and endothelial cells.
Proceeding with the healing process, granulation tissue is substituted for extra
cellular matrix (EMC), made of collagen, elastin, glycoproteins and proteogly-
cans [25].
Moreover, during the inflammation, immune response is carried out by
antibodies, complement components, cytokines, chemokines, growth factors
and other proteins able to detect a foreign agent and to guide cell recruitment
and modifications in order to attack the foreign body.
On this bases, there are some goals that a tissue engineered device has to
achieve in order to work properly in-vivo:
• restoration of the target tissue with its appropriate function,
• inhibition of macrophages and foreign body response which may degrade
the device,
• inhibition of scar and fibrosis formation which may reduce the tissue and
the device functionality, and
• inhibition of the immune response, which would cause severe damages to
the device itself and surrounding tissues [26, 21].
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Cell adhesion and migration Adhesion plays a critical role in the healing
process. It is possible to distinguish between two types of adhesion: cell to cell
and cell to ECM interactions. Both of them are mediated by trans-membrane
receptors, a well as structural and regulatory proteins, which are displayed on
the cell surface [27]. Cell to ECM interactions influence cell spatial distribution
and migration into tissue and organs. Additionally, cell to cell interactions are
necessary to form the three dimensional tissue structure [28].
Three characteristics are shared by all the cell receptors. Firstly, when
attached to their ligand, they tend to assemble into clusters. Secondly, they
are often linked to cytoskeletal structure, allowing the mechanical binding of
the cell to the substrate and mechanical stress transmission. Thirdly, regula-
tory proteins are associated with receptor clusters, which are regulating cell
proliferation and function [29].
Initially, the development of tissue engineered materials focused on obtain-
ing bioinert materials (e.g., titanium, ultra high molecular weight polyethy-
lene...), which had good mechanical properties, and low, a-specific, cell inter-
action. But it was soon clear that it was not the right path to follow; so
devices with a strong cell-material interaction were developed. It was dis-
covered that the increase of cell-device interaction interferes with the natural
cell-cell interaction, leading to a suboptimal tissue development. Therefore,
new biomaterials were developed trying to balance the two types of interac-
tion. The tailoring of the biological surface properties is often obtained by
functionalization of the material by grafting peptides on the surface, inducing
an adequate cellular response. In other cases, it is possible to adjust the adhe-
sion just by changing the surface energy (i.e., by changing the hydrophobicity)
and the electrostatic charges, modifying the protein adsorption and therefore
the cell adhesion [30].
Another important phenomenon affected by cell adhesion is cell migration.
Cell migration plays a key role in tissue formation and integration starting
from cells seeded on the scaffold. Materials treated to improve cell adhesion,
cell migration and in general, biomolecular recognition, often by mimicking
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the natural ECM, are called biomimetic [30]. ECM is a complex mixture of
proteins produced by the cells. It is part of the tissue, and governs the cell
behavior, thus influencing cell migration, growth, division and differentiation.
Cell receptors, which are able to detect ECM signals, are located on the cell
surface, and pass through the cell membrane. In a living tissue, the ECM is
continuously remodelled, to modify the tissue as the need arises. A goal of
tissue engineering is to stimulate ECM production to improve tissue regener-
ation. Increase in the catabolic pathway, which leads to tissue destruction,
should be avoided. To improve their biomimetic properties, implanted mate-
rials can be functionalized with ECM proteins; in this way, the implant will
not be detected as “foreign body”. Moreover, in this way, it is also possible
to modify the cell response to the material. Sheets of highly organized ECM
made of collagen, laminin, proteoglycans and other proteins, called basement
membrane, provide an anchor for cells to adhere and spread through specific
surface receptors, called integrins [31, 32].
1.2 Gelatine
This research focuses on the exploitation of the physical and chemical proper-
ties of gelatine, in order to produce substrates for the tissue engineering. The
first known gelatine use dates back to about 8000 years ago. In those days gela-
tine obtained by boiling animal tissues was used as glue; for the same purpose
gelatine was used by the Egyptians around 3000 B.C. The first documented
use of gelatine for “medical” purposes is probably dated back to around 1150
A.C. when Hildegard von Bingen, Benedictine Abbess and universal scholar,
recommended in her “Physica” frequent eating of broth made from calves feet
as relief from joint pain. For centuries gelatine was considered a special food
for rich people. During the Napoleonic Wars (19th century), due to the block-
ade of the French ports by the British navy, gelatine obtained by boiling bones
was found to be a protein source to replace meat, which was in short supply.
The revolution in the use of gelatine for biomedical applications happened
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in 1833: Mothes, a French pharmacist, patented the manufacture of gelatine
capsules to encapsulate drugs. With these capsules, drugs dosing was much
easier. Gelatine acted as a barrier from heat, cold and humidity and strongly
affected taste: drugs no longer tasted bitter. In the 20th century the use
of gelatine in medicine exploded, ranging from sponges for blood absorption
during surgeries to gelatine-based substances used as blood replacement agents
or plasma expanders [33].
Gelatine is a mixture of proteins obtained by native collagen partial hy-
drolysis; the content of protein ranges from 85% to 92%, the remainder is
constituted by salts and moisture still left after drying [33]. Collagen is a
family of proteins (at least 27 types of collagen are known) contained in the
connective tissues of animal bodies. About one-third of all the proteins in
the human body are collagen. Collagen is structured in triple helices incorpo-
rated in rod-like fibrils; these fibrils can also interact with other proteins [34].
The primary structure of type I animal collagen (used for gelatine production)
is a sequence of amino acids linked to form chains, of about 100 000 g/mol,
which are called α-chains. The α-chain comprises 334 repetitive units of the
sequence glycine-X-Y (where X and Y are other amino acids). Glycine covers
about 33% of the amino acid component; while proline and hydroxyproline
together about 22%. Proline often covers the X-position, while hydroxyproline
is almost always in Y-position. The other amino acids (45%) are distributed in
X and Y position (some positions are preferred due to steric and electrostatic
reasons). Only at the N- and C-terminal ends it is possible to find short chains
(15-26 amino acids), which do not fit the glycine-X-Y model. Proline and
hydroxyproline are responsible for the secondary structure of collagen: they
limit the rotation of the backbone and contribute to the structure of the triple
helix. Type I collagen is composed of three α-chains, two of which are identical
and one slightly different. Each α-chain is coiled into a left-handed helix with
about three amino acids per turn. The three α-chains are then twisted around
each other into a right-handed super-helix to form the rigid rope-like structure
[35, 33].
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Gelatine is produced industrially by treating animal skin (it would be pos-
sible to use also bones, but it is more difficult; so, for economical and practical
reasons, skin is usually preferred, even if gelatine from bones is different from
gelatine from skin) with dilute acids or alkali at a moderate temperature,
inducing partial cleavage in the natural cross-linking present in the collagen
structure.1 2 Due to differences in the cross-linking degree, which depends
on the age of the animal, the hydrolysis treatment may vary slightly from one
batch to the other. The resulting hydrolyzed proteins mixture, the gelatine, is
soluble in warm water. After this step, known as “conditioning process”, the
warm-water soluble gelatine is extracted by melting it out of the raw material
(i.e. the animal skin) through the increase of the temperature of the bath:
here an additional thermal hydrolysis step occurs.
Technically, the conditioning process is not mandatory. Gelatine was pro-
duced for centuries just by boiling hide and bones; anyway, such a long high
temperature process would partially destroy the collagen structure. The col-
lagen structure on the contrary, gentle hydrolysis with diluted acids or alkali
allows to keep almost intact, while eliminating the cross-linking.
By controlling type and intensity of the hydrolysis, it is possible to control
the molecular weight distribution of the obtained gelatine. The molecular
weight distribution is clearly an important parameter since it affects many
properties, for example viscosity and the property, which characterize gelatine:
the gelling power. Both of them are increased by an increase in the molecular
weight. The fraction of molecules around 100 kDa is the most important for
gelling power, while viscosity is mostly affected by higher molecular weights
(200 kDa - 400 kDa). Gelatine hydrolyzed with alkaline treatment (Type B
gelatine) shows a narrower molecular weight distribution (centered on about
100 kDa), when compared to Type A gelatine (obtained by acid hydrolysis),
1Gelatine from pigskin is not produced by basic hydrolysis due to the high amount of fat
contained, which would be saponificated by the alkali, becoming difficult to separate from
the gelatine.
2Another way to produce gelatine would be by enzymatic hydrolysis with collagenases,
but it is not used so frequently in the industry.
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which has a broader distribution. For both gelatine types the molecular weight
ranges from about 10 kDa to 400 kDa [33]
Gelation of gelatine gels is a thermal effect; after cooling a gelatine “solu-
tion” (a gelatine sol, to be more precise) below its gelation temperature (also
called setting temperature), a three-dimensional gel network is formed. The
transition is reversible, so it is possible to “melt” the hydrogel (technically it
is a gel-sol transition) by heating above a certain temperature, usually called
“melting temperature”. The gelation temperature is usually considered to be
5°C below the melting temperature. Anyway, this difference in temperature
may vary depending on the aging condition and time of the hydrogel. The
gelation phenomenon is accompanied by a change in the optical rotation [36];
this has been interpreted as indicating a partial reordering of gelatine molecules
into the original collagen helix. The phenomenon is usually called renaturation
and is divided into three steps: at first, an intramolecular rearrangement of
the imino acid-chain segments occurs, taking on a conformation similar to the
one of the same segments found in the collagen. This step, called collagen fold,
is responsible for the increase in optical rotation. Then by means of the asso-
ciation of two or three separate chains, the formation of the three dimensional
network happens: during this phase crystallite formation, unrelated with the
helical region, can be observed with X-Ray diffraction. The third step involves
the formation of hydrogen bonds within the helical region, which stabilizes the
structure [37]. Gelation is apparently a quick process, but when the quantity
of renaturated helices overtime after gelation is analyzed, it is possible to no-
tice an increase in that value. The ratio of new helices created depends on the
annealing temperature. The annealing process, numerically expressed by the
increase in the helices amount as a function of time, follows a logarithmic law,
and supposedly it can continue until all the helices are renaturated [38, 39].
1.2.1 Properties
Gel strength Gel strength, measured as Bloom Value, is an analytical value
of the gel firmness and it is considered the most important gelatine character-
24 CHAPTER 1. INTRODUCTION
istic. According to the European and U.S. Pharmacopoeia, the gel strength
(Bloom value) is expressed as: “the mass in grams necessary to produce the
force, which, applied to a plunger 12.7 mm in diameter, makes a depression 4
mm deep in a gel having a concentration of 6.67 per cent m/m and matured
at 10 °C”. Commercial gelatine Bloom value ranges from 50 to 300. Higher
gel strength usually means higher melting point, higher gelling temperature,
shorter gelling time, and, of course, higher mechanical properties, which mean
also lower gelatine concentration to achieve a certain firmness. After the con-
stancy of the product between gelatine concentration and square root of the
Bloom value was experimentally observed, an analytical expression correlating
them was found to be [33]:
C1 ×
√
B1 = C2 ×
√
B2
with C1, C2 and B1, B2, respectively concentration and Bloom value of 2
different gelatine solutions. Despite a good degree of correlation, this equa-
tion can be used just as a rough indication to predict properties of different
gelatines; for accurate values, laboratory tests are needed [33].
Molecular weight distribution As anticipated, molecular weight distri-
bution plays a key role in the assessment of some technological properties of
gelatine, like viscosity and gelling power. It is determined by gel permeation
chromatography (GPC). The sample (i.e. gelatine) is dissolved into a buffer
solution and injected into a gel phase chromatographic column, where, every
molecule moves at different speed, depending on the molecular weight. At the
end of the column, an UV detector3 plots the protein concentration on a chro-
matogram. Through the comparison of the retention time and the area of the
picks on the chromatogram with standard samples at known molecular weight,
it is possible to reconstruct the molecular weight distribution of the mixture.
3In some cases viscometric or light scattering detectors can be used instead.
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Melting point The term “melting point” is not exact for gelatine gels: “gel-
sol transition temperature” would be more correct since it gives an idea of the
type of transition which occurrs. Anyway, as commonly done in literature,
also in this thesis the two terms will be used interchangeably. The gel-sol
transition temperature of gelatine hydrogels is affected by many parameters,
including concentration, molecular weight distribution, pH, thermal history
and additives [37]. It is known that by increasing concentration, both setting
and melting temperature increase. It is important to remember that melting
point and setting point have different values.
As anticipated, gelatine gels are characterized by a continuous annealing
process, which involves new helices formation. The formation of new helices
and the stabilization of the junctions between different helices with hydrogen
bonds increase the stability of the hydrogel, consolidating its structure. This
lead to an increase of the melting temperature during the annealing process.
The increase of the annealing temperature (taking care not to reach the gel-
sol transition) reduces the kinetic of new helices formation, but increases the
stability of the junctions. Therefore, more energy is required to melt the
hydrogel; for this reason, annealing at higher temperature leads to a gel with
higher melting point.[38, 39].
As reported by Osorio et al., there is a dependency of the melting tempera-
ture on the pH: the melting temperature is usually maximum for a pH between
6 and 7, and slightly decreases for higher pH values. On the contrary, there is
a remarkable decrease in the melting point for pH below 5 [40].
Additives are widely used to modify mechanical and thermal properties of
gelatine in the manufacturing of capsules and suppositories. The most used
additives for this purpose are glycerol and polyols in general (e.g. sucrose,
sorbitol, maltodextrin...), due to their ability to increase the gelatine strength.
This kind of additives has also the effect to increase the melting temperature.
On the contrary, electrolytes usually reduce both strength and melting point.
Aldehydes, as well as carbodiimides and genipin, are often considered additives:
they react with gelatine inducing chemical cross-linking. Cross-linked gels loose
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their ability to melt [37].
1.3 Objectives
The aim of this research is to develop a gelatine based hydrogel to be used for
wound healing. The gel should be used as cell culture substrate, able to deliver
cells in-situ, and should be easily removable after the treatment. It should also
be effective in delivering growth factors if surgically implanted into a patient
with impaired wound healing.
1.3.1 Specific Objectives
• Develop a hydrogel solid at physiological temperature, and able to melt
at higher (but still harmless) temperature to be used as easily removable
bandage,
• culture cells on the surface of that hydrogel,
• transfer cells cultured on the hydrogel on a different surface, and later,
remove the hydrogel by melting,
• load the hydrogel with growth factors and use it as depot,
• tune the melting temperature and degradation/dissolution kinetic of the
hydrogel to be suitable as anti-surgical adhesions.
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Figure 1.1: the scheme shows the uncross-linked hydrogel applications which
were studied in this work.
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Chapter 2
Membranes for Wound Covering
2.1 Introduction
One big issue in medicine is the removal of bandages which are stuck to an
open wound or sore. Indeed, when it is necessary to remove the dressing to
check the wound, bandage removal typically causes also detachment of the clot
stuck to the bandage itself. This, in turn, causes bleeding, interruption of the
wound healing process, partial destruction of the new formed tissue and pain
for the patient. The problem becomes even more important in case of chronic
wounds, as in case of diabetes.
In the field of wound dressing an uncountable number of different treatment
options can be found. Moreover, new products and technologies are constantly
developed. Some of them are improvements of older products, others are the
results of completely new studies. While traditional wound dressing are mainly
focused on keeping the wound clean, new products try to alter the wound
environment to optimize healing conditions.
While plain gauze is still the most used dressing, devices able to keep
the wound moist and protected have been developed in order to achieve better
healing conditions. The big spread of plain gauzes is certainly related to the low
cost, the ease of use and the versatility. Impregnated gauzes can also provide
29
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better moisture conditions and have reduced adhesion to the wound surface.
To increase the autolytic debridement, occlusive dressing were developed, such
as TegadermTM and DuodermTM. For heavily exudative wounds, absorptive
products, mainly hydrogel based, were developed. Although the higher cost of
these products compared to traditional gauzes, they seem to bring an overall
reduction of the cost per wound, due to a minor number of replacements per
day and faster healing, resulting in a shorter treatment period.
Gelatine sponges have been very useful in the treatment of severe burns
and as a dressing for many types of wounds, such as pressure sores, donor
sites, leg ulcers and decubitus ulcers, as well as for in-vitro tests. US 4,659,572
describes a burn wound-adherent dressing material as composed of a complex
with gelatine and a water-soluble resin, aimed at controlling water-loss and
minimizing the intrusive of exogenous micro-organisms. The gel protection
remains on the wound 7 or more days, and is removed after the starting of the
healing process, when skin grafting is allowed to take place. In US Patent Ap-
plication 2005/0036955, a moldable, bioresorbable, biocompatible, unallergenic
cross-linked gelatine derivative dressing for the prevention of post extraction
alveolar osteitis pain is defined along with methods for the gel use. The dress-
ing is placed at the time of surgery and acts as a bone covering obtundant
and physiologic scaffolding for the conduction of normal alveolar bone healing
sequence of fibroblast ingrowth, blood vessel formation, and reossification of
the extraction site defect. US 5,895,412 describes an apparatus and method to
boost and enhance wound closure in tissue by flowing a heated sealant, such as
gelatine, on the wound. This creates an effective barrier against further blood
leakage and, upon cooling, the sealant readily adheres to the tissue to seal the
wound.
For wound protection and skin healing, extensive investigation has been
carried out on the hydrophilic and water absorbing properties of gelatine as a
clinical wound dressing [41].
Traditional or prior art gels act as a matrix for controlled release, but they
do not act for an almost immediate release. In topical uses, such as in wound
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healing, it is better to have the release of a high concentration of the adjuvant
agents (such as platelet rich plasma, PRP) in a short time. Further, if the gel
melts naturally at body temperature or is washed away with a warm solution
(38 °C - 40 °C), the wound is not affected. By contrast, if there is the necessity
to remove a solid gel, which is stuck to the wound, its removal provokes both
pain and the reopening of the wound.
Moreover, there is the need for a gelatine hydrogel, which allows the con-
tact between platelet derived components (including, but not limited to PRP
and platelet lysate (PL), platelet poor plasma (PPP), cryoprecipitate (CRYO)
alone or together with other therapeutic agents) and wounded skin or organ
injury, on which the platelet components can release growth factors and en-
hance their healing properties. In particular, in skin treatment, an immediate
contact of all available platelet components with the skin injuries would favor
both the repairing process and the growth of regenerated skin. If the skin in-
jury is continuously in contact with fresh platelet components (including PRP
and PL) by mean of a suitable delivery system, rapid regeneration will occur,
even when replacing the delivery system [42, 43].
There is also the need for a gel film that can be easily placed as a pro-
tecting barrier against infection on skin wounds or injuries that is not painful
to remove. The gel may contain biologically active agents and may be used
on skin wounds or lesions due to burning or to relieve bedsore or metabolic
ulcers. Removal of the film is often painful given the adhesion of the gel onto
the wounds. A hydrogel system which is in a gel state at the temperature of
the skin (33 °C) but “melts” when water at a temperature compatible to the
body (36 °C - 38 °C) is poured onto it, would be removed easily and without
pain.
Moreover, the hydrogel system needs to be composed of biocompatible,
bioresorbable and biodegradable materials, preferably from natural sources
(not synthetic) and not chemically modified, such as cross-linked. Among the
materials, pure gelatine (not cross-linked) has proven to possess the character-
istics of being biocompatible, bioresorbable and biodegradable. It also has a
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better biocompatibility than other natural products, such as albumin [44].
The use of gelatine gels and cross-linked collagen gelatines has been inves-
tigated, so far, as “depot” systems, which slowly release the biologically active
agents for a prolonged release. However, gelatine matrix degradation is ob-
served in such gels. The degradation occurs after a long period of time and in
different forms, such as enzymatic erosion and dissolution,. The degradation
kinetic depends on the application site (i.e., from 6 - 8 hours in ophthalmic
applications, where the elimination is in general very fast, to 7 - 10 days in
other body districts, such as skin).
Gelatine-based systems have a common characteristic: they are solid at
37 °C, with a melting temperature- (i.e., a gel-sol transition temperature) much
higher than the body temperature (the melting temperature is usually at least
43 °C - 45 °C or more). The commercial advertisements for gelatine focuses
also on this point. They stress that gelatine melting point is to be considered
a quality index. In other words, a higher melting point is advertised as both
an index of good gelatine and a sign of good stability. It is also advertised
that gelatines will lose activity, denature and degrade when the temperature
is substantially higher than their melting point. Thus, the loss of activity will
mainly occur with low melting gelatines.
Therefore, the right choice for the gelatine to be used in the above medi-
cal applications is to select the one with a melting point as high as possible.
There is still the need for an improved gelatine hydrogel, which allows the easy
removal of the gelatine gel films, or other forms, from wounded skin (burning,
bedsore) without any damage or pain.
Since gelatine has a gel-sol transition temperature comprised between 30 °C
and 37 °C, it could be a good candidate as material for the making of bandages
easy to remove. In order to use gelatine gels as wound dressing, it is necessary
to have a gel-sol transition temperature higher than the skin temperature,
which is typically below 33 °C - 34 °C (it depends on the body part, on the
temperature of the environment and there are differences between subjects).
To better understand gelatine properties a study on the factors which influence
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the transition temperature has been carried out.
Gel-sol transition temperature of gelatine gels is influenced by several fac-
tors: the first, and most important factor, is the source of gelatine. Gelatine
from mammalian collagen shows a gel-sol transition temperature, which ranges
from 30 °C to 37 °C, while the one of gelatine from fishes typically ranges from
about 10 °C to 28 °C, depending on fish species and on the temperature of the
water, where they live [45]. For this reason, gelatine from porcine skin was
selected for this research.
Gelatine gels are also influenced by the gel water content (i.e gelatine con-
centration). As a matter of fact, an increase in water content causes a decrease
in the gel-sol transition temperature [40]. The water content can be controlled
in different ways, depending on the technique used to prepare the hydrogel: if
the gel is prepared by solution casting, the final concentration of the gel will
be the same of the solution, while, if it is prepared through water absorption
from dry gelatine, the water content will depend on the soaking time and the
absorption kinetic. Equilibrium value and absorption kinetic, as explained in
section 2.3.4, depend on temperature.
The pH of the gelatine solution is another important factor, which affects
gelation and gel-sol transition: lowering the pH usually induces a reduction of
the melting temperature. However, changes are more relevant in the range 3 -
6, so keeping pH around 7 is sufficient to avoid gel-sol transition temperature
reduction[40].
The gel-sol transition temperature of the gelatine hydrogel is greatly af-
fected by the thermal history both of the gel itself, and of the gelatine used
[38, 46, 47, 48].
2.2 Materials and Methods
In order to develop a device able to resist the body temperature, but easy
to remove by melting, gelatine hydrogels at different concentrations were pro-
duced. As anticipated, thermal properties of gelatine hydrogels are greatly
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affected by the their thermal history. In order to exploit the results obtained
by Djabourov et al. [39], one tried to increase the thermal resistance of the
gelatine gels by annealing them at 29 °C for 48 hours. For a complete descrip-
tion of the production process please refer to section 2.2.1.
2.2.1 Gelatine Preparation
The procedure used for gelatine sample preparation was optimized in 6 steps,
described below:
1. Sterilization Dry gelatine powder was sealed in Polypropylene falcon
tubes and sterilized by γ-ray radiation (dosage: 25 Gy) by Gammarad Italia
s.p.a.
2. Dissolution Gelatine solution was prepared by soaking sterile gelatine
powder in sterile water or cell culture medium for 10 minutes, at room temper-
ature, to allow gelatine swelling, by absorbing a certain amount of liquid. The
suspension was then placed in a 37 °C bath for 1 hour, and stirred every 20
minutes by using a vortex mixer until a clear gelatine solution was obtained.
To reduce bubbles and foam on the surface (induced by the stirring process),
the solution was finally centrifuged at 2300 relative centrifugal force (rcf) for 5
minutes. After centrifugation, the gelatine solution was placed again into the
37 °C bath for 10 minutes, in order to avoid gelation in the pipette during the
casting process.
3. Casting and Gelation Gelatine solution at 37°C was cast into polystyrene
tissue culture plates (TCPs); different plate sizes and solution volumes were
used, depending on the need. To induce gelation, the solution was kept for
24 hours in an incubator, at room temperature (20°C) and at 100% relative
humidity (RH).
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4. Annealing Gelatine gels, prepared as previously described, were moved
to a 29°C oven, at 100% RH, and maintained in this condition for 48 hours.
The annealing process performed at 29 °C for 48 hours induces the formation
of stable triple helices, which leads to an increase of the gel-sol transition
temperature, if compared with the one of the untreated gels [39].
5. Freeze drying To produce a gelatine sponge, the gel produced by so-
lution casting, as described in step 3, was frozen at -80°C for 24 hours and
freeze-dried for 3 days at -50 °C, and 0.1 mbar. Resulting sponges can be
stored for months in a dark, dry place at room temperature, and, when nec-
essary, they can be rehydrated just by soaking in water, culture medium or
plasma derivatives.
6. Drying Gelatine gel, produced by solution casting as described in step
3, was dried in a ventilated drying oven at 50°C. After 48 hours, a solid,
transparent and brittle film was obtained.
Also in this case, the samples can be stored for months in a dark, dry place
at room temperature, and, when necessary, they can be rehydrated just by
soaking in water, culture medium or plasma derivatives.
2.2.2 Mechanical Compression Test
Stiffness of gels 5%, 10% and 15% gelatine in water, prepared as described in
section 2.2.1, step 3, and of others, at the same concentrations, prepared as
described in 2.2.1, step 4, was tested according to ASTM standard D695-10.
Samples were cut in cylindrical shape (diameter: 0.5 inch; height: 4 mm), and
tested by means of an Instron 4502 (testing speed: 1.3 mm/min), working at
23 °C and 33 °C, in a thermostatic chamber at 100% RH. Three samples per
type per temperature were tested.
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Figure 2.1: Rapid cooling device. It is composed by a copper plate immersed
in liquid nitrogen, the hydrogel was leaned on the non-immersed area
2.2.3 Samples Preparation for Scanning Electron Microscopy
In order to analyze the gel porosity, samples, prepared as described in section
2.2.1 step 4, were frozen with a high cooling rate and observed at the Field
Emission Scanning Electron Microscope (FE-SEM). The high cooling rate was
achieved by a self constructed device, constituted of a copper plate (4x40x50
mm), immersed into liquid nitrogen, leaving only a small area ((10x40 mm)
exposed to the air, as shown in figure 2.1. Gelatine gels were placed on the
exposed area of the plate, achieving a high cooling rate due to the low tempera-
ture of the liquid nitrogen (-195.79°C), and the high conductivity of the copper.
After samples were completely frozen, they were cryo-fractured, exposing the
inner part, moved to a lyophilizer, and freeze-dried at -50°C and 0.1 mbar,
for 24 hours. Once removed from the lyophilizer, samples were immersed in
silver-paste (except for the face to observe) to increase the conductivity with
the stub. They were then observed by using the FE-SEM (Supra 40, Zeiss),
through the detection of Secondary Electrons.
2.2.4 Dynamic Scanning Calorimetry (DSC)
The influence of concentration and annealing on the gel-sol transition of a gela-
tine hydrogel was studied by using Differential Scanning Calorimetry (DSC,
Mettler DSC 30). DSC is a thermoanalytical technique, which measures the
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difference in thermal flow between a sample and a reference, to maintain both
of them at the same temperature. The analysis is typically carried out heating
(or cooling) both the sample and the reference at some rate. The difference
in thermal flow is then plotted as a function of the temperature; in this way
it is possible to identify at which temperature a some change in the heat flow
happens. Changes in the thermal flow are caused by transformations in the
material; some of them are exothermic (e.g. crystallization), others are en-
dothermic (e.g. fusion, boiling). By analyzing the thermogram shape (and
knowing the possible transitions, which can occur in the material), it is pos-
sible to infer which transformation happened at each temperature (e.g. glass
transition is a flex, melting is an endothermic peak).
Analysis on gelatine samples were performed increasing the temperature
from 2 °C to 60 °C in order to be sure to include the gel-sol transition for each
concentration and annealing treatment. The heating rate was set to 1°C/min
since, from preliminary tests, there was no appreciable difference reducing
this rate. Only one scan was performed, since the first scan induces a gel-sol
transition, which modifies the material irreversibly.
2.2.5 Water Absorption
Water absorption quantification test was performed by soaking gelatine gels,
films, or membranes, in water, at room temperature (20 °C). After 15 minutes,
30 minutes, 60 minutes, 2 hours, 4 hours, 6 hours and 24 hours, samples
were strained and weighted. The water uptake was calculated as a percentage
increase in weight, compared with the initial weight of the sample, according
with the formula:
WaterUptake =
Wwet −Wdry
Wdry
· 100
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Gelatine Conc. Annealing E at 23°C (KPa) E at 33°C (KPa)
5 6.9± 1.8 2.7± 0.6
5 YES 7.0± 1.7 2.6± 0.9
10 34.9± 2.3 2.9± 0.3
10 YES 34.7± 1.9 2.8± 0.8
15 79.6± 3.0 23.2± 3.0
15 YES 79.9± 2.6 22.9± 3.1
Table 2.1: Mechanical compression of gelatine gels, performed according to
ASTM standard F2900-11.
2.3 Results and Discussion
2.3.1 Mechanical Compression Test
In order to evaluate the influence of concentration, annealing and temperature
on the gelatine gel stiffness, compression tests were performed, according to
ASTM standard D695-10-11, as described in section 2.2.2. Concentrations
used to perform the tests were 5%, 10% and 15% gelatine in water. Tests were
performed at 23 °C and 33 °C, 100% RH.
Results As shown in table 2.1, the stiffness is greatly affected by both con-
centration and temperature. Testing temperatures were chosen below the melt-
ing temperature. However, the decrease in stiffness at 33°C, especially for
diluted samples, is evident, even if melting was not reached.
On the contrary, annealing does not affect the stiffness at all.
2.3.2 Gel micro- and nano-structure
Micro- and nano-structure of gelatine hydrogels were analyzed by the Scanning
Electron Microscope (FE-SEM). Gels were prepared as described in section
2.2.1, rapidly frozen at -195.79°C on a copper plate, and freeze-dried. Samples
were then included in silver paste, to increase the conductivity between them
and the stub, and observed by using the FE-SEM. For the complete protocol,
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Figure 2.2: gelatine sample FE-SEM image acquired on the cryofracture area,
near the surface in contact with the copper plate (smooth area): the gel poros-
ity is clearly visible.
please refer to section 2.2.3.
Results Figure 2.2 shows the nanostructure near the surface in contact with
the copper plate (i.e., the smooth area visible on the image). The size of
the small fibers is compatible with the one of collagen fibers, as reported in
literature [49]. Due to the extremely quick freezing process used, the porosity
observed near the surface can be supposed to be the gel porosity, since it should
not be affected by ice crystal growth.
The image acquired in the central part of the sample (figure 2.3) shows
big pores, with small fibers on the boundary. These big pores were produced
by the growth of ice crystals during the freezing process, because of the low
cooling rate, and thus they can be considered an artifact. No appreciable
morphological differences were detected between normal and annealed gels.
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Figure 2.3: gelatine sample FE-SEM image acquired on the cryofracture area,
far from the surface in contact with the copper plate: the big porosity is due to
ice crystal growth during the freezing process (square). Small fibers of collagen
are visible on the bottom of the big pores (arrows).
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Figure 2.4: DSC comparison between untreated gelatine gels (heating rate:
1°C/min): the endothermic peak indicates the gel-sol transition.
2.3.3 Differential Scanning Calorimetry
In order to evaluate the influence of concentration and annealing treatment
on gelatine gels, two batches of gelatine gels prepared as shown respectively in
sections 2.2.1 , step 3 (for untreated samples) and step 4 (for annealed samples),
were analyzed by DSC, as described in section 2.2.4. Three concentrations per
batch were chosen: 5%, 10% and 15% in weight.
Results As shown in figures 2.4 and 2.5, the increase of the concentration
from 5% to 15% rises the melting temperature of the untreated gelatine from
about 34 °C to about 36 °C, while for annealed samples there is a smaller
difference, from about 37 °C to 38 °C.
A more interesting comparison is the one between annealed and untreated
samples, prepared with the same concentration. As shown in figures 2.6, 2.7
and 2.8, the melting temperature of annealed samples is about 2 °C higher than
the one of untreated samples. Comparing the three figures it is also possible
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Figure 2.5: DSC comparison between annealed gelatine gels (heating rate:
1°C/min): the endothermic peak indicates the gel-sol transition.
to notice that the increase in melting temperature of the most concentrated
sample (figure 2.8) leads to a broadening of the pick: a possible explanation for
this broadening could be the presence of a wider distribution of bonding energy,
in the gelatine. Weaker bonds break at lower temperature while stronger at a
higher one. This wider distribution can depend on the fact that at a higher
concentration, chain mobility is partially impaired by other chains: for this
reason some of them cannot reach the more stable condition induced by the
annealing process.
2.3.4 Water Absorption
In order to understand the behavior of a gelatine gel immersed in cell cul-
ture medium and tailor the soaking time of a freeze-dried gelatine bandage,
a water absorption test was performed on both dried gelatine gels (prepared
as described in section 2.2.1, step 6), and freeze-dried gelatine membranes
(prepared as described in section 2.2.1, step 5). The tests were performed as
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Figure 2.6: DSC comparison between 5% untreated and annealed gelatine gels
(heating rate: 1°C/min).
Figure 2.7: DSC comparison between 10% untreated and annealed gelatine
gels (heating rate: 1°C/min).
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Figure 2.8: DSC comparison between 15% untreated and annealed gelatine
gels (heating rate: 1°C/min).
described in section 2.2.5
In figure 2.9 the water uptake curve is shown as a logarithmic plot.
The logarithmic kinetic for the dried sample is evident. On the other
hand, the water uptake of the freeze-dried is comparable to the dried one in
the first 2 hours; successively it seems to increase more rapidly. This difference
on the kinetic could be explained referring to the porosity of the freeze-dried
sample. When it is immersed in water, the water is initially not able to enter
the pores, since the porosity on the surface is small, the gelatine surface is
hydrophobic and the water surface tension is too high to allow water to enter
those hydrophobic pores. When gelatine absorbs water, the surface changes
and so its wettability. As a consequence, the water is able to diffuse and fill the
porosity. Once pores are filled, the contact area between gelatine and water
is bigger than in the case of the compact gel. For this reason the absorption
kinetic increases. This data interpretation is also confirmed by the observation
of the freeze-dried sponge while it is absorbing water. Initially the presence of
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Figure 2.9: Water Uptake in dried gelatine and freeze-dried sponges.
micrometric air bubbles inside the wet sponge is clear, but after 2 hours it is
possible to notice a reduction of the bubbles, which continues until each pore
is filled.
Similar experiments were carried out with medium and PRP and they gave
the same results.
2.4 Conclusions
Due to their ability to protect the wound, absorb exudates and maintain moist
the environment, cross-linked or highly concentrated gelatines are extensively
studied as wound dressing materials. While cross-linked materials have lost
their ability to melt, the highly concentrated uncross-linked ones present a
melting temperature over 45 °C. In this work it was analyzed the possibility to
produce uncross-linked gelatines, with a melting temperature between 35 °C
and 40 °C. As shown in section 2.3.4, these gelatines can absorb, quite quickly,
large amounts of water. This property can be exploited to produce dry gelatine
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bandages, which can be stored at room temperature and rehydrated when
necessary. Moreover, the possibility to absorb liquids is an important property
once gelatine is used to dress wounds, especially in case of highly exudative
wounds.
A consequence of the annealing process on gelatine gels is an increase of the
gel-sol transition temperature, without the addition of chemicals. Technically,
it involves a sort of cross-linking, which, in this case, is thermo-reversible, as
previously discussed in section 1.2. Therefore, the possibility to melt the gel
is not impaired as in the case of chemical and dehydrothermal cross-linking.
However, the most interesting property of the studied gelatine, is the pos-
sibility to remove it from the wound by melting / washing with warm sterile
water. This allows the detachment and removal of the wound dressing with-
out damaging the newly formed tissue. Additionally the pain for the patient
during the removal of gelatine membranes is greatly reduced, if compared with
traditional gauzes.
Chapter 3
Cell Sheet Engineering on
Gelatine
3.1 Introduction
Aim of this work, as already anticipated, was to culture confluent cell layers
on gelatine hydrogel surfaces, in order to realize easily transferable cell sheets.
Since fibroblasts are of great importance in the wound healing process, it was
decided to start working with this cell type. In particular, MRC-5 cell line was
chosen and used as a model. In future work they could be changed with other
cell types in order to solve different problems.
Gelatine hydrogels, used as substrate for cell sheets, can be melted at
physiological temperature, as shown in section 2.3.3. This characteristic allows
to easily remove them by melting, once the cell sheet is transfered on the
surface, which has to be treated. Indeed, it is sufficient to use warm sterile
water (37 °C - 40 °C) to completely dissolve gelatine hydrogels in a few minutes,
after the cell sheet has adhered to the target surface. Moreover, if implanted
into the body, gelatine takes less than one week to dissolve/degrade without
the need of removal, since gelatine is reported to be non-toxic, biocompatible,
non-carcinogenic and non-immunogenic (please, refer to chapter 5 for more
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details and explanations) [50].
Due to the possibility to quickly remove gelatine by melting and washing it,
it is possible to apply several cell sheets, possibly made of different cell types,
one above the other, in order to face up a particular problem. This technique
would allow to obtain a thicker tissue made of stacked cell sheets, similar to
what was described by Yamato et al. [51]. An interesting example is the use
of fibroblasts followed by keratinocytes, for ulcer and burn treatments.
Cell culturing on a surface is the only way to allow cells to rapidly adhere
to an injured area. Indeed, if cells are inside a matrix, they cannot be rapidly
transferred on a target region: it becomes, therefore, necessary to leave the
whole scaffold in place to allow the slow cell migration process.
The main problem when culturing cells on gelatine, is the cell culture pro-
cess itself. Indeed, gelatine, when immersed in water (or in a culture medium),
continuously absorbs the liquid (chapter 2.3.4); the increase in water content
reduces the gel melting temperature below the standard cell culture tempera-
ture (37 °C). As a consequence, cells cannot be cultured at 37 °C on normal
gelatine hydrogels immersed in culture medium.
Different approaches have been tried in order to increase gelatine gel gel-sol
transition temperature: most of them were focused on partial cross-linking (e.g.
dehydrothermal treatment, cross linking with 1-ethyl-3-(3-dimethylaminopropyl)-
carbodiimide(EDC)), others relied on blending with hydrogels with higher gel-
sol transition temperature (e.g. agar-agar), but none of them worked for the
purpose. Cross-linking led in fact to the loss of the gel-sol transition, while
blending did not increase the melting temperature at all. Only two alterna-
tives were then possible: cell culture on cross-linked gelatine (renouncing to
the gel-sol transition), and cell culture at reduced temperature.
3.2 State of the Art
Cell-sheet engineering was developed by Okano et al. to overcome polymeric
scaffold and cell suspension limitations. The target was to reconstruct tissues
3.2. STATE OF THE ART 49
starting from cell sheets instead of single cells. Although cell suspension injec-
tion achieved some results in small animals, it does not seems to be suitable for
large tissue reconstruction, due to the low percentage of cells really integrating
into host tissues.
The main advantage of cell sheets, compared with traditional tissue engi-
neering, is the absence of scaffolds. Scaffolds are useful to culture cells in-vitro,
but, when implanted in-vivo, they often present some limitations. One of them
is the degradation time, ranging from weeks to months. During degradation,
the space occupied by the scaffold is filled with proliferated cells and deposited
ECM. However, ECM deposition in tissues, following an implant and con-
sequently an inflammation, often results in fibrosis. Furthermore, for some
applications, scaffolds impair organ functionality, as it happens in the case of
opaque scaffolds for corneal regeneration.
From a histological point of view, many organs are structured as intimately
associated cell sheets. For example, liver comprises interconnected layers of
hepatocytes and endothelial cells.
Temperature-responsive Tissue Culture Plates Traditionally, cells are
harvested using proteolytic enzymes, such as trypsin or dispase. These enzymes
cleave protein bonds between cells and culture substrate. Unfortunately, these
enzymes destroy also cell-cell and cell-ECM bonds. To overcome this prob-
lem, temperature-responsive culture dishes were developed. A temperature-
responsive polymer, poly(N-isopropylacrylamide)(PNIPAAm), was grafted onto
the surface of TCP. At 37 °C, the surface is hydrophobic, such as standard
TCPs, and allows cell culture, but under 32 °C it becomes hydrophilic, in-
ducing cell detachment without any needs of proteolytic enzymes. Avoiding
enzymes, cell-cell junctions and receptor proteins are not affected by the pro-
cess. Therefore, cells can be harvested as continuous cell sheet. Harvested cell
sheets can then be transferred into other TCPs, implanted in-vivo, or stacked
on other cell sheets to form thicker layers.
One of the most interesting applications of cell sheet engineering shown by
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Okano et al. was the regeneration of ocular surfaces. Limbal stem cells were
isolated from the patients and expanded on temperature-responsive culture
dishes. Once continuous layers were formed, they were detached from the
TCP by reducing the temperature under 32 °C. The harvested cell sheets were
continuous and easily manipulated. They were then moved on corneal stromas
of injured eyes. The sheets adhered to the new surfaces without the need of
suture. In all the patients an increase in the visual acuity was observed.
Traditional tissue engineering tried to produce scaffolds for the culture
of cardiomyocytes. However, there were problems related to the stiffness of
the material, which hampered the dynamic pulsation of the cardiomyocytes.
Okano et al. showed that layering several cell sheets of confluent cardiomy-
ocytes allowed the production of pulsatile myocardial tissue. Synchronous tis-
sue pulsation indicates good conductivity between different lamina sheets. A
stack of four sheets was sufficient to see the spontaneous pulsation with naked
eyes. Most recent cell sheet applications include treatment of esophageal ul-
ceration, periodontal tissue, lung air leak and pancreatic islet tissue.
At the moment cell sheet technology presents some limitations in the pro-
duction of 3D constructs. Although it is possible to stack cell sheets to form
three dimensional tissues, it is difficult to achieve cell survivability into thick
layers, mainly due to insufficient nutrient diffusion and waste accumulation in
the central part of the layer. Actually, the highest thickness for in-vivo cell
survivability is approximately 80 µm [52]. Therefore, to achieve higher thick-
ness, a polysurgery approach is necessary, adding cell sheets once the previous
is vascularized [52]. To overcome this limitation and allow in-vitro culture of
thicker tissues, the production of a capillary-like structure has been explored.
This particular structure has been achieved adding micro-patterning technique
to the cell sheet engineering [53].
Cell sheet engineering demonstrated to have a wide-range potential for tis-
sue reconstruction. With the addition of the recently studied micropatterning
techniques, it could be possible to extend cell sheet technology to thick het-
erogeneous and vascularized tissues .
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3.3 Materials and Methods
3.3.1 Cell Subcultivation
In order to subcultivate the fibroblasts (MRC-5) cells (please refer to section
3.1 for the explanation of this cell line choice), a commonly used protocol was
followed. It consists of few steps, which are briefly described below.
Before reaching confluence fibroblast (MRC-5) cells were subcultivated in
a polystyrene tissue culture flask, under normoxia (air plus 5% CO2), using a
seeding density of 1·104 cells/cm2. The medium composition is showed in table
A.1. The medium was changed twice per week. The cells were then detached,
after rinsing 2 times in phosphate buffered saline (PBS), using trypsin 0.05% -
EDTA 0.02% in PBS for 3 minutes at 37°C. After that, trypsin was quenched
by adding a volume of culture medium four times the trypsin one. Cells were
counted in a Bürker chamber and cell viability was measured by trypan blue
exclusion. Cell suspension density was successively adjusted depending on the
need.
3.3.2 Cell culture on EDC cross-linked gelatine
1. Cross-linking In order to produce a gelatine substrate without gel-sol
transition, and in order to evaluate the possibility of culturing cells on it and,
successively, transferring the obtained cell layer to a target surface, gelatine
gels 15% gelatine in water were prepared as described in section2.2.1, step 4.
After the annealing procedure, gels were soaked in a solution 2% of EDC in
water for 15 seconds, at room temperature; then, they were extracted from
the solution and rinsed with abundant water to remove the unreacted reagent.
EDC was chosen as cross-linker, because of its water solubility and its ability
to cross link proteins, and, since it is a zero-lenght cross-linker (i.e. after the
cross-linking process, no EDC residual chains will remain attached to the pro-
tein). Successively, samples were left in water for 2 hours; water was changed
frequently in order to allow reaction products diffusion and elimination. It
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was not possible to produce the gelatine gel using culture medium, instead
of water, due to changes (e.g. pH) induced by the medium. These do not
allow the EDC to react and cross-link the gelatine without the addition of N-
hydroxysulfosuccinimide (Sulfo-NHS). It was preferred to avoid the use of NHS
and Sulfo-NHS in order to reduce the number of residual substances potentially
cytotoxic in the hydrogel.
2. Cell Culture In order to evaluate the possibility of culturing cells on
cross-linked gelatine hydrogel surfaces, and successively transfer the obtained
cell layer to a target surface, cross-linked gelatine gel was prepared as previ-
ously described. Before cell seeding the cross-linked gel surface was soaked
in cell culture medium (table A.1) for 2 hours, in order to allow the diffusion
of the medium inside the gel, and protein adsorption on the surface, which
increases cell adhesion.
Fibroblast (MRC-5) cells were seeded on the cross-linked surface at a cell
density of 1 · 104 cells/cm2 and incubated at 37 °C in culture medium. The
culture was checked every 24 hours by using a phase contrast microscope. An
empty well per plate was seeded with the same amount of cells, as control. 6
hours after seeding, the samples and the control were covered with medium to
ensure the cells proper hydration.
After the formation of a confluent layer (i.e. after 84 hours), samples were
moved to a new TCP with seeded side down, ensuring a good contact between
the cell layer and the TCP. After an incubation of 24 hours, the cross-linked
gelatine gels were removed and the presence of an adherent cell layer on the
plate was checked by using both a phase contrast microscope and a confocal
laser microscope.
3.3.3 Cell culture protocol development
To develop a new protocol for cell culturing on gelatine gels, a multi-step
procedure was followed during which the preliminary results obtained were
used to optimize the following steps.
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1. Cell culture at different temperature Gelatine gels prepared as
described in section 2.2.1, step 4, were seeded with fibroblasts (MRC-5), at a
seeding density of 1·104 cells/cm2. Samples were divided into three groups and
incubated respectively at 31 °C, 32 °C and 34 °C for 24 hours into multi-well
TCPs. An empty well per plate was seeded with the same amount of cells, as
control. 8 hours after seeding, the samples and the control were covered with
medium to ensure the cells proper hydration. 2 hours, 8 hours and 24 hours
after seeding, the samples were observed at the phase contrast microscope.
2. Cell culture on dry surface Gelatine gels prepared as usual (section
2.2.1, step 4), were seeded with fibroblasts (MRC-5), at a seeding density
of 1 · 104 cells/cm2. The samples were then incubated at 31 °C into multi-
well TCPs. As before, an empty well per plate was seeded with the same
amount of cells, as control. After 2 hours cell adhesion was checked by using
a phase contrast microscope. Half samples were then re-incubated at 31 °C in
“dry” conditions (i.e. without adding any liquid medium), the others were re-
incubated at 31 °C in standard culture conditions (i.e. immersed in the culture
medium). All the samples were observed after 2 hours, 8 hours, 24 hours and
48 hours by using the phase contrast microscope.
3. Cell culture on barely wet surface Also in this case gelatine gels were
prepared as usual (section 2.2.1, step 4), and seeded with fibroblasts (MRC-5),
at a seeding density of 1 · 104 cells/cm2. The samples were then incubated at
31 °C into multi-well TCPs, in which it was prepared the usual control well.
After 6 hours cell adhesion was checked by using a phase contrast microscope.
Samples were then kept at room temperature for 15 minutes to allow gelatine
to cool down. Successively 100 µL of medium, at room temperature, were
added to each sample (well diameter: 34 mm), before re-incubating at 31 °C.
The adding of new medium (100 µL) to each sample was repeated twice per
day following the same protocol. All the samples were observed every 24 hours
by using the phase contrast microscope.
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4. Cell seeding density test Gelatine gels were prepared following the
usual procedure described in section 2.2.1, step 4. Cells, previously subcultured
as described in section 3.3.1, were seeded on sample surfaces at different seeding
density: 1 ·104 cells/cm2, 2 ·104 cells/cm2, and 4 ·104 cells/cm2. Samples were
then incubated at 31°C, and cultured re-wetting the surface twice per day as
described above (section 3.3.3, step 3).
5. Cell culture - optimized procedure Gelatine gels were prepared fol-
lowing the procedure described in section 2.2.1, step 4. They were then seeded
with fibroblasts (MRC-5), previously subcultured as shown in section 3.3.1,
with a seeding density of 2 ·104 cells/cm2. Successively the samples were incu-
bated at 31 °C in multi-well TCPs. An empty well per plate was seeded with
the same amount of cells, as control. After 6 hours, cell adhesion was checked
by using a phase contrast microscope. Samples were then kept at room tem-
perature for 15 minutes to allow gelatine to cool down. Successively 100 µL
of medium, at room temperature, were added to each sample (well diameter:
34 mm), before re-incubating at 31°C. The adding of new medium (100 µL) to
each sample was repeated twice per day following the same protocol. Once per
day, just before one of the two medium additions, samples were firstly placed
at room temperature for 15 minutes. Successively they were completely im-
mersed in culture medium at room temperature for 10 minutes. After this, all
the liquid medium was removed and 100 µL of medium were added, as usual,
before re-incubating at 31 °C. All the samples were observed every 24 hours
by using the phase contrast microscope.
3.3.4 DNA quantification - PicoGreen
In order to evaluate the cell proliferation on the samples cultured at 31 °C,
three DNA quantification tests were performed (before the seeding, after 24
and after 72 hours of culture). For these analyses, the Quant-iT PicoGreen
dsDNA Assay Kit (Invitrogen, cat. n. P11496) was used. The aim of this
assay is the quantification of the DNA content in a sample. The DNA content
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is directly related to the number of cells on the sample. After DNA extraction,
by destroying cell and nuclear membranes, PicoGreen is used as fluorescent
staining for the fluorimetric analysis.
Fibroblasts (MRC-5) were seeded on 6 gelatine samples at a seeding density
of 1 · 104 cells/cm2.
2 of them were immediately melted at 37°C and centrifuged at 1300 rcf
for 10 minutes, to separate the cells from the gelatine. After removing the
gelatine, the cells were moved to 2 empty wells, covered with 500 µL Triton-X
0.05%, and stored at -20 °C. These samples were used as reference.
The other 4 samples were incubated at 31 °C and cultured as described in
section 3.3.3 step 5.
24 hours after seeding 2 incubated samples were melted and centrifuged as
the reference samples. The cells separated through centrifugation were moved
to 2 empty wells, covered with 500 µL Triton-X 0.05%, and stored at -20 °C.
48 hours later the 2 remaining samples were melted, centrifuged and frozen
as previously described.
48 hours after the freezing of the samples, both reference and cultured
samples were thawed at room temperature, transferred to 1.5 mL tubes, and
sonicated for 10 seconds by using Hielscher UP400S, (cycle: 1, amplitude:
40%) to break cells and nuclei. Tubes were soaked in ice just after sonication,
in order to avoid DNA denaturation.
A calibration curve was prepared by mixing respectively 400, 200, 100, 40,
20, 10, 4, 0 µL of DNA lambda (2 µg/mL), with 0, 200, 300, 360, 380, 390, 396,
400 µL of TE buffer. Both the DNA lambda and the TE buffer were provided
with the DNA Assay Kit.
A 96-well plate was prepared with the 8 standards for the calibration curve
(3 wells per concentration), the 2 references (2 wells per sample), and the
cultured samples (2 wells per sample), loading 100 µL per well.
Successively, 100 µL of PicoGreen working solution, provided by the DNA
Assay Kit, were added to each well.
After 3 minutes of incubation at room temperature, standards and samples
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were read on a fluorescent plate reader (TECAN Infinite M200, excitation
wavelength: 485 nm, emission wavelength: 538 nm).
A calibration curve was built using the average values of the 8 standards.
Samples DNA content was then evaluated by interpolation on this curve. Sam-
ples frozen after seeding and samples cultured were compared in order to eval-
uate the increase in the cell number during the culture.
3.3.5 Cell Viability and 3D distribution
Fibroblast (MRC-5) cells were seeded on 15% gelatine hydrogel prepared as
described in chapter 2.2.1 step 4, and cultured for 21 days following the pro-
cedure shown in section 3.3.3, step 5. After this, samples were washed three
times with PBS and incubated with Calcein AM 4mM for 10 minutes at 31 °C
before analyzing them by using the Confocal Laser Microscope (Nikon A1,
excitation wavelength: 488 nm, detection wavelength: 525 nm).
3.3.6 Histological Analysis
Cell-sheets cultured on gelatine at 31 °C as described in section 3.3.3 step 5,
for one week, were rinsed in PBS, cut in 4 pieces, and soaked in 10% formalin
neutral buffered (HT501128 Sigma) for 24 hours for fixation.
Dehydration After fixation samples were rinsed in water for 4 hours, then
dehydrated and prepared for inclusion in paraffin by immersion in a sequence
of different solutions:
• 50% ethanol, 1 hour
• 50% ethanol, 1 hour
• 70% ethanol, 1.5 hours
• 70% ethanol, 1.5 hours
• 70% ethanol, 1.5 hours
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• 96% ethanol, 1 hour
• 96% ethanol, 1 hour
• 100% ethanol, 1 hour
• xilene, 15 minutes
• xilene, 15 minutes.
Inclusion and Cut Samples were then immersed in liquid paraffin at 60 °C
for 2 hours, allowing it to penetrate into the samples. After that time samples
in paraffin were left to solidify in the fridge (3 °C). Once solidified, samples were
cut in 5 µm thick histological sections, with cuts parallel and perpendicular to
the cell sheet plane. Paraffin was then removed from the cut samples by im-
mersion in xilene for 10 minutes. Samples were then rehydrated by immersion
in a sequence of ethanol solutions at decreasing concentrations:
• 100% ethanol, 5 minutes
• 100% ethanol, 5 minutes
• 90% ethanol, 5 minutes
• 70% ethanol, 5 minutes
and then soaked in water for 5 minutes. Samples were then divided into two
groups and stained with hematoxylin and eosin (H&E) and van Gieson staining.
H&E staining The staining process was performed by soaking in a sequence
of different solutions:
• Mayer’s hematoxylin (1g/L), 10 minutes
• warm water, until violet tone
• eosin G, 30 sec
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• distilled water, 10 sec
• ethanol 70%, 5 sec
• ethanol 80%, 5 sec
• ethanol 90%, 5 sec
• ethanol 100%, 10 sec
• ethanol 100%, 10 sec
• xilene, 10 sec
• xilene, 10 sec
van Gieson staining The staining process was performed by soaking in a
sequence of different solutions:
• Weigert’s iron hematoxylin stainng solution, for 15 minutes
• rinse in distilled water
• wash in running water, 10 minutes
• rinse in distilled water
• Van Gieson’s staining solution, 1 minutes
• rinse in distilled water
• rinse in ethanol 70%
• dehydrate rapidly in ethanol 100%
• xilene, 10 sec
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Dehydration Stained samples (both H&E and van Gieson) were then dehy-
drated by soaking in a sequence solutions:
• ethanol 50%, 5 minutes
• ethanol 70%, 5 minutes
• ethanol 90%, 5 minutes
• ethanol 100%, 5 minutes
• ethanol 100%, 5 minutes
• xilene, 5 minutes
• xilene, 5 minutes
Observation Pictures of the samples prepared as described above were
acquired by using the optical microscope (Zeiss Axiotech).
3.3.7 Cell Transferring
Because of gelatine future applications, it was necessary to develop a procedure
to transfer cells cultured on gelatine gels from sample surfaces to a different
substrate (figure 3.1). The optimized transfer method consists of few steps:
1. Fibroblasts (MRC-5) were seeded with a seeding density of 2·104 cells/cm2
on gelatine gels, prepared as usual (section 2.2.1, step 4). All the samples
were incubated and cultured following the optimized method described
in section 3.3.3, step 5.
2. 72 hours after seeding, the transfer procedure started: gels were moved
to a new TCP with the seeded side down, maintaining the cell layer in
contact with the polystyrene TCP.
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3. Before carrying on with cell incubation under standard conditions (37 °C,
100% RH, normoxia), samples were analyzed by using the optical micro-
scope
4. In order to monitor both gelatine melting and adhesion process, cells
were checked again by using the optical microscope after a 60-minute
incubation.
5. 90 minutes after the beginning of the transfer, melted gelatine was re-
moved and samples rinsed with warm medium (37 °C), before carrying
on the incubation at 37 °C (immersed in medium, in standard cell culture
conditions).
6. In order to remove any residual gelatine, medium was changed again 90
minutes after step 5, and cells were observed with the optical microscope.
7. The analysis was repeated 24 and 48 hours after the transfer.
8. After the last check by using the optical microscope (48 hours), cells
were rinsed with PBS, stained with Calcein AM 4mM for 10 minutes ant
37 °C, and observed with the fluorescence microscope.
3.4 Results and Discussion
3.4.1 Cross-linked gelatine
The use of an EDC cross-linked gelatine, which does not swell when soaked in
culture medium and does not undergo gel-sol transition at the culture temper-
ature, allows cell culture on this kind of gelatine in standard conditions [54].
The drawback is the impossibility to detach the cells by melting the gelatine.
Ultra-thin cross-linked gelatine gels were produced following the method
described in section 3.3.2 step 1, and used as substrate for fibroblast culture
(section 3.3.2). As already told, this procedure allowed to obtain a gelatine
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Figure 3.1: scheme of the cell sheet transferring process.
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Figure 3.2: Confluent fibroblasts (MRC-5) on EDC cross-linked gelatine after
84 hours after seeding.
with only the superficial cross-linked layer, due to the short soaking time in
the cross-linking solution. It was therefore possible to remove the inner part
of the substrate by melting, but not the thin cross-linked layer, which is the
culture substrate.
Cells grown on cross-linked gelatine surface reached confluence in 84 hours.
Figure 3.2 shows the layer of confluent fibroblasts, which are aligned with the
gelatine surface roughness (the big visible network is a cotton lint placed under
the gel in order to handle it easily). Unfortunately, due to gel thickness and
surface bending, caused by the swelling of its internal part (uncross-linked), it
was not possible to observe the cells with the phase contrast microscope.
When placed on the polystyrene TCP for the transfer step, cells could not
to completely detach from the cross-linked gelatine and adhere to the plate
surface in a short time. Therefore, it was not possible to transfer cells using
this culture substrate. As a consequence, the choice to use cross-linked gelatine
as fibroblast culture substrate was given up.
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3.4.2 Cell culture protocol development
Since the use of cross-linked gelatine as a substrate for fibroblast cell sheet
culturing was given up, it was necessary to develop a novel cell culture tech-
nique, able to avoid (or at least reduce) water absorption by gelatine. This is
necessary because water absorption causes a reduction in the gelatine concen-
tration, which leads to a reduction of the gel-sol transition temperature and,
as a consequence, to the “melting” of the substrate during the culture. The
substrate melting during the culturing process would cause cell detachment,
followed by cell sinking into the gel and finally cell adhesion to the bottom of
the TCP, making the whole process useless. The first parameter which had to
be changed was the culture temperature, since it was not possible to culture
cells on uncross-linked gelatine at 37 °C. Successively it became necessary to
change the medium addition (i.e., cell feeding) technique, in order to improve
the quality of cell culture after 24 hours. Finally, due to its increased melting
temperature (please, refer to section 2.3.3), gelatine prepared as described in
section 2.2.1 step 4, was chosen to perform cell culture tests.
1. Temperature Reduction Since temperature plays a key role determin-
ing gelatine gel properties, it was necessary to find the best temperature at
which to perform the cell culture.
There were no reliable analytical methods to determine how the temper-
ature should be changed in order to achieve the best result; a try and error
approach was therefore chosen, in which cultures at different temperatures
were compared. Tests were performed at a temperature some degrees below
the gelatine melting temperature in order to avoid the melting of the surface
exposed to the liquid medium, which otherwise would swell, thus lowering its
gel-sol transition temperature.
Cells were then cultured on annealed samples (section 2.2.1 step 4) at 31 °C,
32 °C and 34 °C, as described in section 3.3.3 step 1, and observed by using
the phase contrast microscope after 2, 8, and 24 hours.
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Figure 3.3: fibroblasts (MRC-5) cultured on gelatine at 31 °C. The image was
acquired 2 hours after seeding.
Results Comparing the images acquired 2 hours after seeding (figures
3.3, 3.4 and 3.5) no difference could be observed between samples cultured at
31 °C and 32 °C. Both samples showed signs of cell adhesion: attaching to
the surface, indeed, cells started to elongate. On the contrary, on the sample
cultured at 34 °C there was no evidence of elongation, which usually indicates a
lower degree of adhesion or a lower cell activity. The differences in the number
of cells appearing in the images were not related to the culturing conditions or
seeding density used, but they were only due to the fact that the images were
acquired on different areas.
8 hours after seeding, (figures 3.6, 3.7, and 3.8) there were still no difference
between samples cultured at 31 °C and 32 °C: adhesion increased and cells
elongated further. However, signs of adhesion could now be observed also
on the sample cultured at 34 °C, mainly as deformation of cells caused by
focal adhesion. The substrate did not seem to be stiff enough to sustain cell
spreading.
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Figure 3.4: fibroblasts (MRC-5) cultured on gelatine at 32 °C. The image was
acquired 2 hours after seeding.
Figure 3.5: fibroblasts (MRC-5) cultured on gelatine at 34 °C. The image was
acquired 2 hours after seeding.
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Figure 3.6: fibroblasts (MRC-5) cultured on gelatine at 31 °C. The image was
acquired 8 hours after seeding.
Figure 3.7: fibroblasts (MRC-5) cultured on gelatine at 32 °C. The image was
acquired 8 hours after seeding.
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Figure 3.8: fibroblasts (MRC-5) cultured on gelatine at 34 °C. The image was
acquired 8 hours after seeding.
24 hours after seeding, both round and spread cells were visible, on the
sample cultured at 31 °C (figure 3.9). Spread cells were correctly attached
to the gelatine surface, while round ones were less adhered or showed a lesser
degree of activation. On samples cultured at 32 °C and 34 °C, the spreading was
much lower: cells were almost round in shape, which indicates poor adhesion,
probably due to too soft a substrate.
48 hours after seeding (figure 3.12), also the sample cultured at 31 °C
showed a reduction in the amount of spread cells, indicating a certain degree
of cell detachment probably caused by the swelling of the gelatine gel.
2. Cell Culturing on Dry Surface Once the best culture temperature was
found, another problem became evident: after some days during which sam-
ples were cultured at reduced temperature and in standard culture conditions
(i.e., samples were immersed in culture medium, in a polystyrene multi-well
TCP), gelatine swelled absorbing medium and the cell sheets which formed on
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Figure 3.9: fibroblasts (MRC-5) cultured on gelatine at 31 °C. The image was
acquired 24 hours after seeding.
Figure 3.10: fibroblasts (MRC-5) cultured on gelatine at 32 °C. The image was
acquired 24 hours after seeding.
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Figure 3.11: fibroblasts (MRC-5) cultured on gelatine at 34 °C. The image was
acquired 24 hours after seeding.
Figure 3.12: fibroblasts (MRC-5) cultured on gelatine at 31 °C. The image was
acquired 48 hours after seeding.
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the substrate surface detached themselves and shrunk (similar contraction for
detached cell sheets was observed by Matsuda et al. [55]). Considering that:
• cells are seeded on a hydrogel constituted by 85% of cell culture medium,
• and the sample is inside an incubator which provides an environment
with 100% relative humidity (RH),
a new culture method was developed, in order to overcome the issue previously
described. This new method consisted of culturing human fibroblasts on a
gelatine surface at 31 °C, with no medium covering the surface.
Fibroblasts (MRC-5) cultured at 31 °C on the surface of a dry annealed
gelatine gel, were compared with cells cultured on gelatine immersed in culture
medium (section 3.3.3 step 2).
Results Dry samples presented a good cell spreading, comparable with
the one shown by samples cultured in standard conditions (at 31 °C) up to 8
hours after seeding (figures 3.13 and 3.14). To the naked eyes it was possible
to notice that the surface was still slightly wet, due to the medium contained
in the drop used for cell seeding.
After 24 hours (figure 3.15) cells on dry samples were mostly round, and
to the naked eyes, it was possible to notice the total dryness of the surface.
This excessive dryness was partially due to gelatine absorption and swelling,
and partially to evaporation from the gel surface. Despite of the presence of
water inside the incubator in order to maintain 100% RH, a certain degree of
evaporation was noticeable. The round shape of the cells was in this case a
symptom of sufferance induced by the surface dryness.
In figure 3.16a it is also possible to notice the effect of drying after 24 more
hours: cells were mostly suffering, while cells on the wet surface (figure 3.16b),
were partially round but in good conditions.
At the end of the test some mL of medium were added to a dry sample,
as shown in figure 3.17: 24 hours after the medium addition, cells started to
spread again, but with an unusual shape.
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a:
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Figure 3.13: fibroblasts (MRC-5) on a dry sample (a), and on a wet samples
(b). The images were acquired after 2 hours culturing at 31°C, by using the
phase contrast microscope.
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a:
b:
Figure 3.14: fibroblasts (MRC-5) on a dry sample (a), and on a wet samples
(b). The images were acquired after 8 hours culturing at 31°C, by using the
phase contrast microscope.
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a:
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Figure 3.15: fibroblasts (MRC-5) on a dry sample (a), and on a wet samples
(b). The images were acquired after 24 hours culturing at 31°C, by using the
phase contrast microscope.
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a:
b:
Figure 3.16: fibroblasts (MRC-5) on a dry sample (a), and on a wet sample
(b). The images were acquired after 48 hours culturing at 31°C, by using the
phase contrast microscope.
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Figure 3.17: fibroblasts (MRC-5) cultured on a dry surface for the first
24 hours, and immersed in medium for the next 24. The image was acquired
at the end of the culture (i.e., after 48 hours), by using the phase contrast
microscope.
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3. Cell Culturing on Barely Wet Surface As previously shown, the
cell culturing on dry gelatine ran properly until the surface did not dry too
much (i.e., for a time ranging from 24 to 48 hours). For this reason, new
culture conditions were developed to maintain the right amount of liquid on the
sample surface, without suffering of an excessive swelling of the gelatine. It was
decided to perform, twice a day, small medium additions on the sample surface.
Preliminary tests showed a certain degree of cell detachment associated with
each medium addition. This phenomenon was interpreted as the reaction to
the quick swelling of the warm gelatine (31 °C) caused by the medium addition.
For this reason, prior to adding medium, samples were cooled down to room
temperature for 15 minutes. In order to avoid thermal shock, also the added
culture medium was heated to room temperature.
Fibroblasts (MRC-5) were cultured on annealed gelatine (section 2.2.1 step
4) at 31°C, adding twice a day 100 µL of medium on the surface at room tem-
perature, as described in section 3.3.3 step 3. Cultured samples were observed
by using the phase inversion microscope every 24 hours.
Results After the first 24 hours of incubation on a “barely wet” surface
(figure 3.18) a significant difference in the cell behavior, in terms of adhesion
and spreading, was observed. Cells which previously reverted to round shape
in 48 hours (please refer to the test on dry sample and on completely immersed
in medium described in steps 1 and 2), in this case maintained for weeks their
elongated shape, typical of adherent fibroblasts. Moreover, no remarkable
differences could be observed between samples with different culture times
(figures 3.18 to 3.21).
4. Seeding Density Seeding density is an important parameter in most of
cell cultures, in particular when cells are cultured at a reduced temperature,
since cell proliferation is much reduced in relation to cultures performed at
standard temperature (37 °C) [56, 57], as successively described in section 3.26.
Moreover, fibroblasts are known to stop proliferation and migration when they
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Figure 3.18: fibroblasts (MRC-5) cultured on a "barely wet" gelatine at 31 °C.
The image was acquired 24 hours after seeding by using the phase contrast
microscope.
Figure 3.19: fibroblasts (MRC-5) cultured on a "barely wet" gelatine at 31 °C.
The image was acquired 48 hours after seeding by using the phase contrast
microscope.
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Figure 3.20: fibroblasts (MRC-5) cultured on a "barely wet" gelatine at 31 °C.
The image was acquired 72 hours after seeding by using the phase contrast
microscope.
Figure 3.21: fibroblasts (MRC-5) cultured on a "barely wet" gelatine at 31 °C.
The image was acquired 96 hours after seeding by using the phase contrast
microscope.
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get in contact each other: this phenomenon was called “contact inhibition”
by Abercrombie and Heaysman [58, 59, 60, 61]. Since the aim of this work
was to obtain a confluent layer of fibroblasts, bound to each other in order to
hold together during the transfer process, the seeding concentration should be
almost as much as the cell density at confluence. This allows cells to reach
confluence in short time, in order to trigger the ECM production to reinforce
the cell sheet before transferring.
To determine the best seeding density value, cells were seeded on the sample
surface at 3 different seeding densities: 1 · 104 cells/cm2, 2 · 104 cells/cm2 and
4 ·104 cells/cm2. Successively, they were incubated at 31 °C with wet surfaces,
which were re-wet twice a day, as described in step 3 (please, refer to section
3.3.3 step 4 for the details).
Results It is known that 24 hours after seeding, cells cultured at 31 °C
show a very low proliferation rate [56, 62]; therefore this culture time was taken
as reference for seeding density comparison.
In figure 3.22 it was possible to notice that cells seeded at 1 · 104 cells/cm2
were not enough to reach confluence in 24 hours.
On the contrary, cells seeded at 2 · 104 cells/cm2 (figure 3.23) formed an
almost confluent layer, as required.
It was interesting to observe what happened when cells were seeded at
higher density. At 4 · 104 cells/cm2 (figure 3.24), cells formed a multilayer
structure, well spread on the surface.
Unfortunately, continuing the culture, the limit became evident. After 48
hours of culture, multi-layered cells detached from the surface, and collapsed
in a huge cell cluster made of cells mostly round in shape (figure 3.25). After
this contraction, the layer diameter was usually 1/3 of the initial diameter (i.e.,
when cells were attached and spread).
5. Cell Culture - optimized procedure Cell culture procedure developed
in step 3 represented an improvement of the protocol used for cell culturing
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Figure 3.22: MRC-5 on gelatine, 24 hours after seeding, seeding density 1 ·
104 cells/cm2, cells spread, unable to reach confluence.
Figure 3.23: MRC-5 on gelatine, 24 hours after seeding, seeding density 2 ·
104 cells/cm2, cells spread forming a monolayer.
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Figure 3.24: MRC-5 on gelatine, 24 hours after seeding, seeding density 4 ·
104 cells/cm2, cells spread and formed a multilayer structure.
Figure 3.25: MRC-5 on gelatine, 48 hours after seeding, seeding density 4 ·
104 cells/cm2, the cell sheet has detached and contracted forming a huge cell
cluster.
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on gelatine at reduced temperature, since the use of this protocol allowed to
culture cells on thermo-reversible gelatine almost as it were cultured on a TCP.
Anyway, to improve the method, it was necessary to develop a procedure for
the replacement of the medium contained in the gelatine. The same medium
remains inside the gelatine for several days while culturing, an obvious reduc-
tion of nutrients overtime (partially consumed by cells, and partially naturally
degraded, e.g. L-glutamine), together with a waste stagnation occur.
The only way to replace the culture medium inside a gelatine substrate,
without detaching the cells seeded on the surface, was by exploiting the diffu-
sion, at a temperature at which gelatine does not swell too much. Therefore,
it was decided to add another step to the culture protocol.
Once a day gelatine samples were removed from the incubator and left at
room temperature for 15 minutes. Then they were soaked in culture medium
at room temperature for 10 minutes. Successively they were extracted and
a culture medium addition was performed as explained in step 3, before re-
incubation at 31 °C. Please, refer to section 3.3.3 step 5 for a more detailed
description of the procedure.
3.4.3 DNA quantification
In order to evaluate the cell proliferation on the samples cultured at 31 °C, the
DNA content of samples incubated on gelatine at 31 °C for 24 and 72 hours,
was compared with the DNA content of the ones analyzed just after seeding.
The DNA content is directly related with the number of cell in the sample;
therefore, it was possible to determine the increase of the cell number during
the culture. For the detailed protocol, please refer to section 3.3.4.
Results In figure 3.26 the slight increase in the cell number after 24 hours
of cell culturing at 31 °C is shown. On the contrary, no increase in the DNA
quantity can be detected after the successive 48 hours of culture. This reduc-
tion in the mitotic activity, after 24 hours of culture at reduced temperature,
is reported also by Enniga et al. and Thompson [56, 57]. However, the spread
3.4. RESULTS AND DISCUSSION 83
Figure 3.26: DNA quantification results: cells cultured at 31 °C for 24 hours
showed a slight increase in number if compared with the reference sample. 48
hours later the cell number seems to be unchanged.
of the DNA content data, which is probably related to the difficulty to har-
vest the cells after the centrifugation step, does not allow to exclude a small
increase in the number of cells even after 24 hours of culture.
3.4.4 Cell viability and migration
Culturing cells on a gelatine substrate, for a relatively long time, in non stan-
dard conditions of temperature and feeding (as described in section 3.3.3 step
5), led to the necessity to check the cell viability. Different techniques are
used to analyze standard samples; but due to the special conditions required
for cell culture on gelatine (mainly for the impossibility to incubate at 37 °C),
it was chosen to use the confocal laser microscope after staining with calcein
acetoxymethyl ester (AM). This because the analysis of samples stained with
calcein AM not only allows to evaluate the cell viability, but also to observe
shape and three-dimensional cell distribution on the surface and inside the
hydrogel.
Calcein AM is a non-fluorescent, hydrophobic compound, able to enter
the membrane of live cells with intact membranes. The hydrolysis of Calcein
AM by endogenous intracellular esterases produces calcein (figure 3.27), a hy-
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Figure 3.27: calcein acetoxymethyl ester (non fluorescent) esterases reaction
which produces calcein (fuorescent).
drophilic strongly fluorescent compound which, due to its hydrophilicity, is
retained in the cytoplasm. Moreover, calcein AM does not stain dead cells,
and is rapidly lost under conditions that cause cell lysis. For these reasons,
stained cells are certainly still living.
In order to test the survivability of fibroblasts cultured on gelatine at re-
duced temperature, fibroblasts (MRC-5) were seeded on 15% gelatine and cul-
tured for 21 days, following the procedure described in section 3.3.5. Succes-
sively living cell distribution was observed by using the confocal laser micro-
scope.
Results In figure 3.28 the stacked view of the gelatine sample (i.e., from
above) is shown.
These cells were not only on the surface, but also partially penetrated into
the gel during the culture period, as shown in figures 3.29 and 3.30, which
are 3D reconstruction of the same part of the gel. This penetration was not
assignable to an excessive swelling and to a consequent softening of the gel,
because in this case cell detachment would be evident. On the contrary fibrob-
lasts aligned perpendicularly to the surface, as in figure 3.30, indicated cell
migration.
In figure 3.31, different cell orientations at different depths are evident.
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Figure 3.28: stacked view of a full thickness sample of fibroblasts (MRC-5)
cultured on gelatine at 31°C for 21 days. The image was acquired after seeding
by using the confocal laser microscope.
Figure 3.29: 3D reconstruction (top view) of a full thickness sample of fi-
broblasts (MRC-5) cultured on gelatine at 31°C for 21 days. The image was
acquired after seeding by using the confocal laser microscope.
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Figure 3.30: 3D reconstruction (side view) of a full thickness sample of fibrob-
lasts (MRC-5) cultured on gelatine at 31°C for 21 days. The cell penetration
depth is about 140 µm. The image was acquired after seeding by using the
confocal laser microscope.
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Figure 3.31: 3D reconstruction (bottom view) of a full thickness sample of
fibroblasts (MRC-5) cultured on gelatine at 31°C for 21 days. The image was
acquired after seeding by using the confocal laser microscope.
3.4.5 Cell Sheet Histology
In order to analyze the morphology of the cell sheets cultured on gelatine at
31 °C, histological analyses were performed.
For the histological tests, fibroblasts (MRC-5) were cultured at 31 °C on
gelatine hydrogels for 7 days following the procedure described in section 3.3.3
step 5. Successively, the samples were fixed in formalin, dehydrated and em-
bedded in paraffin. Samples were then cut in slices 5 µm thick, with both
horizontal and vertical cross-section as shown in figures 3.32 and 3.33. His-
tological sections were stained with hematoxylin and eosin (H&E), and van
Gieson staining, in order to show the cell distribution. The detailed protocol
followed for the histological preparation was described in section 3.3.6.
Results The first interesting result deduced by means of this test was
reached before cell fixation: the sample cut (figure 3.34) showed the presence
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Figure 3.32: scheme of the horizontal cross-section (gelatine in yellow, cell-
sheet in black, and the plane of section in red).
Figure 3.33: scheme of the vertical cross-section (gelatine in yellow, cell-sheet
in black, and the plane of section in red).
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Figure 3.34: cell sheet after the cut with the bistoury (black arrows), prior to
the fixation in formalin. Slight contraction of the sheet, mechanically detached
from the surface by the cut, is clearly visible (white arrow). The image was
acquired by using the phase contrast microscope.
of a continuous layer made of cells and ECM on the surface. After the cut this
layer slightly contracted because of a mechanical detachment induced by the
bistoury blade.
In figure 3.35 a horizontal cross-section of the sample cut as described in
figure 3.32 is shown: the presence of cells is shown by nucleus stained in blue
(by means of hematoxylin). The cut was not perfectly parallel to the cell sheet
surface, due to difficulties in blade alignment and sample irregularity. However,
it is possible to notice the presence of a dense cell layer on the sample surface.
In figures 3.36a and 3.36b a vertical cross-section of the sample, obtained
as sketched in figure 3.33, is shown. It is possible to notice the cell sheet
cross-section, which appears as a film slightly detached from the surface. This
detachment was induced by mechanical stresses while preparing the histological
sections. The sheet seems to be continuous and not formed by single cells
attached to the surface of the gelatine substrate, indicating strong interactions
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Figure 3.35: histological section (horizontal), stained with H&E, dark spots
represent cell nuclei. The image was acquired at the optical microscope.
between the cells forming the layer. Moreover, cells are clearly confined into
the superficial layer, indicating the use of ideal culture conditions for cell sheet
formation.
Samples stained by using van Gieson protocol provided no additional results
to what was deduced after analyzing samples stained with H&E.
3.4.6 Cell Sheet Transferring
In order to demonstrate the possibility to transfer the developed cell sheet on
a wound or an injured organ (figure 3.1), it was necessary to test the transfer
method on a substrate easy to analyze. The surface chosen to perform the
transfer test, was a polystyrene TCP, since it gave the possibility to perform
further analysis and to carry on with the culture.
To carry out the test cell sheet samples were prepared seeding the fibrob-
lasts (MRC-5) on the gelatine gel (seeding density: 2 · 104 cells/cm2) and
culturing them at 31 °C (section 3.3.3 step 5). Such a cell sheet was then
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Figure 3.36: histological section (vertical), stained with H&E, dark spots rep-
resent cell nuclei. In (a) is shown the cell sheet almost completely adherent to
the surface, in (b) a detachment of the cell sheet, induced during the prepara-
tion of the histological section is clearly visible. The images were acquired at
the optical microscope.
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Figure 3.37: cell sheet cultured on gelatine at 31 °C for 72 hours, just placed
in contact with the TCP at 37 °C (transfer start). The image was acquired by
using the optical microscope.
transferred to a TCP and kept it in contact with the surface, as described
in section 3.3.7. Once adhesion occurred (i.e., after 90 minutes), cells were
rinsed repeatedly with culture medium to remove residual gelatine and con-
firm cell adhesion. Cell culture was carried on in standard culture conditions
to demonstrate cell activity and mobility once re-incubated at 37 °C [56, 62].
Results Figure 3.37 shows a cell sheet cultured on gelatine at 31 °C
for 72 hours. This picture was acquired after placing it on the TCP (i.e., the
moment at which the transfer process started). In order to assess the shrinkage
occurring during the transfer process, a cell sheet, which was small enough to
be fully comprised into the picture, was chosen. Images were acquired without
the phase contrast objective, to allow lower magnification, and therefore the
availability of a bigger area inside the picture.
After 60 minutes at 37 °C gelatine appeared to be melted, but cells had
not shrunk yet (figure 3.38).
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Figure 3.38: cell sheet cultured on gelatine at 31 °C for 72 hours, 60 min-
utes after the transfer start. The image was acquired by using the optical
microscope.
After 90 minutes shrinkage started, indicating the complete melting of the
substrate. Melted gelatine was then aspirated and the TCP, with the attached
cell sheet, was rinsed with medium. In figure 3.39 a small shrinkage is clearly
visible, which is typical of fibroblast cell sheets detached from the culture
substrate [63]. The small entity of the shrinkage indicates the sheet adhesion
to the new substrate (i.e. the TCP); differently, cells would shrink completely,
forming a big cell cluster.
In the following images, specially in figure 3.41, acquired after 24 hours of
incubation at 37 °C, cell clusters were evident, indicating a sub-optimal adhe-
sion or a light detachment in these sheet areas, as confirmed by the position of
these clusters. They were in fact distributed on the sheet boundaries, which
are the most stressed zones and which can be detached by the medium flow
while rinsing. However, the presence of these clusters indicated a good inter-
action between cells in the sheet, otherwise they would be washed away by the
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Figure 3.39: cell sheet cultured on gelatine at 31°C for 72 hours, 90 minutes
after the transfer start. Melted gelatine was removed. The image was acquired,
after rinsing with warm medium (37°C), by using the optical microscope.
medium.
After 48 hours of incubation at 37 °C cells were reorganizing on the surface
and migrating from the clusters to the surface, making clusters less visible
(figure 3.42). Since it was difficult to observe cells spread on the TCP without
phase contrast, they were stained with Calcein AM. This one allows to verify
their living state too.
In figure 3.43, the spreading on the surface is evident, even if clusters are
still visible.
3.5 Conclusions
The importance of avoiding gelatine melting during cell culturing is evident.
Moreover, the experimental results shown in section 3.4.2 step 1 pointed out
also the importance of avoiding the swelling on the culture surface. Swollen
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Figure 3.40: cell sheet cultured on gelatine at 31°C for 72 hours, 180 min-
utes after the transfer start. The image was acquired by using the optical
microscope.
gelatine presented a much lower stiffness, further reduced at higher tempera-
ture, as shown by the compression test (section 2.3.1). This stiffness decrease,
associated with a lower concentration of “protein” inside the swollen gel, greatly
reduced cell adhesion, as deduced by the round shape of the cells. Gels incu-
bated at 31 °C showed a much better behavior, with less swelling and, therefore,
good cell spreading in the first 24 hours, if compared with samples cultured at
32 °C and 34 °C.
Initially the cell culture on dry surface (section 3.4.2, step 2) seemed to be
a promising technique, since cells were cultured on a substrate constituted by
85% of cell culture medium, in an incubator with 100% RH: unfortunately it
was not possible to keep cells alive for more than 24 hours without medium
additions. Adding medium 24 hours after incubation started, led to an inter-
mediate condition: after 24 more hours of incubation (figure 3.17), cells were
able to spread again, but with an unusual shape, probably due to some de-
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Figure 3.41: cell sheet cultured on gelatine at 31°C for 72 hours, 24 hours
after the transfer start. Clusters caused by small detachments and shrink-
age on boundaries are evident. The image was acquired by using the optical
microscope.
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Figure 3.42: cell sheet cultured on gelatine at 31°C for 72 hours, 48 hours after
the transfer start. Cell clusters are disappearing due to cell migration to empty
surface. The image was acquired by using the optical microscope.
Figure 3.43: cell sheet cultured on gelatine at 31°C for 72 hours, 48 hours
after the transfer start. Living cells were stained with Calcein. The image was
acquired by using the fluorescence microscope.
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gree of migration inside the gel during the drying. However, this test proved
that cells were still alive, even if round in shape, after 24 hours on the dry gel
surface.
In case of cells cultured on an uncross-linked gelatine, the adding of the
right amount of medium on the surface greatly affected the cell spreading. As
shown in section 3.4.2 step 3, cells unable to spread on the surface if completely
covered by the medium, spread perfectly when the medium periodically added
to the samples was barely sufficient to wet the surface. The ideal quantity of
medium was carefully added to the culture to reach an ideal dry surface just
before the next addition, i.e. avoiding the excessive drying showed in figure
3.15 and 3.16. An excessively dry surface can be easily detected at the phase
contrast microscope, since, in these conditions, cells appear as blisters protrud-
ing from the surface; on the contrary, whet a correct hydration is reached, a
smooth surface is visible.
As easily predictable, the seeding density is a fundamental parameter for
reaching confluence in low temperature cell culture. The results shown in sec-
tion 3.4.2 step 4, underlined the importance not to exceed a threshold value
identified as the optimal seeding density. Exceeding the optimal seeding den-
sity brings to an irreversible cell sheet detachment and to a successive con-
traction, which transform it into a huge cell cluster. Fibroblast contraction
is natural, but since it brings about the formation of scar tissue it should
be avoided (using the right seeding density) [64], in order to reach the best
conditions for the culture and the cell sheet transferring.
It is known that fibroblasts can produce proteolytic enzymes able to cleave
collagen and, therefore, gelatine. This degradation allows them to migrate
across the surface and remodel the extracellular matrix and the gelatine hy-
drogel [65, 66, 67, 68]. As shown in section 3.4.4, cells cultured on gelatine
hydrogels at 31 °C for 3 weeks were able to migrate into the gelatine matrix
forming a 3D network. By exploiting this cell behavior would be possible to
produce 3D structures made of cells and gelatine, while retaining the ability
to remove the scaffold (i.e., gelatine) by melting, once cells have produced a
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consistent extracellular matrix. This feature would be even more interesting
considering how “traditional” cell-sheet engineering solved the problem of ob-
taining 3D structures: by stacking cell layers [63, 51, 69], which implies low
interpenetration between layers. It is also interesting to notice the different
orientations of cells in the 3D structure (figure 3.31), similarly to what happens
in the connective tissue. However, culturing cells into thick gelatine scaffolds
present some problems: firstly the diffusion of nutrients and wastes, which
limits the depth of cell migration, secondly, the reduced proliferation rate typ-
ical of such a low culture temperature [56, 62]. Multi-step seeding would be
probably needed to obtain higher cell density in the matrix, to avoid the cell
sheet contraction shown in high seeding density (section 3.4.2, step 4).
The main preoccupation given by these experimental procedures came
largely from the possibility to damage cells with the permanence at reduced
temperature for a relatively long time. Thompson et al. [57] studied the effect
of temperature on the longevity of MRC-5 human fibroblasts as number of
passages before senescence. A passage is roughly the number of duplications
a cell had, so it is an indicator of how old the cell is. In that work, Thompson
showed an irreversible diminution of cell longevity when culture temperature
is higher than 37 °C (40 °C). This reduction was probably induced from errors
in the protein synthesis related to the temperature increase. On the contrary,
in the case of culture at lower temperature, a different behavior was observed:
cells maintained at 32 °C showed a reduced proliferation, and a reduced mitotic
activity. However, moving back the cells to 37 °C, their proliferation rate was
recovered and they reached the same number of passages as cells kept at 37 °C
for the whole culture process [57]. Similar results were obtained by Enniga et
al.: they showed a decrease in the fibroblast proliferation rate at 30 °C, with
a sharp decrease after 25 hours of culturing. They also indicated that mitosis
was stopped in the G1 phase (gap 1 phase). However, after reverting to 37 °C,
cells started to proliferate again, recovering their normal state [56, 62].
The main aim of this thesis was to develop a new material for the pro-
duction of cell sheets, able to transport living cells into the body and degrade
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/ dissolve in a few days. In section 3.4.6 it was demonstrated the possibility
to transfer fibroblast cell sheets from the uncross-linked gelatine substrate, on
which they were cultured, to a target surface (i.e., a polystyrene TCP used
as a model). Once transfer ended, gelatine melted and ensured an easy re-
moval. Finally one should not underestimate that staining with calcein made
it possible to show the cell viability on the transferred cell sheet.
Chapter 4
Films for bioactive molecule
release
Gelatine gels showed interesting in-vivo dissolution-degradation time, when
loaded with plasma derivatives (see chapter 5), and the consequent possibil-
ity to use them as depot, to release proteins in-situ for a time ranging from
hours to weeks. Therefore, in collaboration with the department of Oncology,
Biology and Genetics, University of Genoa, with the Ludwig Boltzmann Insti-
tute for Experimental and Clinic Traumatology of Vienna, and the National
Cancer Research Institute of Genoa, we decided to test the in-vivo release of
pro-angiogenic factors from gelatine hydrogels, in a model of ischemic fascio-
cutaneous flap.
4.1 Introduction to skin flaps
Skin flaps are routinely used by plastic surgeons for the functional and cos-
metic repair of wounds and defects left behind after traumatic injuries and
malignancy removals [70]. A fascio-cutaneous flap consists of three layered
vascularized tissues: reticular dermis, hypodermis and the underlying fascia.
A flap grafting failure can occur because of surgery complications such as in-
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fections, denervations, inadequate fluid drainage (hematoma/seroma). Flap
survival mainly depends on the blood supply, either non specifically (ran-
dom flap) or specifically (pedicle flap) provided through vessels of the der-
mal and subdermal plexus [71]. A lack of oxygen and nutrients especially in
the distal part of the flap often results in a partial necrosis with devastating
results for the patient. The complexity of events associated with ischemia,
such as production of reactive oxygen species, neutrophil influx, depletion of
NO and apoptosis have directed the counteracting therapy towards pharma-
cological approaches, including use of antioxidants [72], vasodilators [73], and
anti-inflammatory drugs [74]. The recent concept of therapeutic angiogene-
sis has emerged as another attractive approach to enhance blood supply and
perfusion in compromised flap tissues. Therapeutic angiogenesis is defined as
the administration of pro-angiogenic factors in order to convert an ischemic
tissue into a viable and functional tissue through the maintenance of existing
vasculature or by stimulating the formation of new vessels [75, 76]. Local and
systemic application of angiogenic proteins, such as PDGF [77], basic FGF [78]
and VEGF [79] have been demonstrated to improve the survival of compro-
mised flaps, while fibrin sealants have been investigated for their hemostatic
and adhesive properties and for the ability to locally deliver and sustainably
release growth factors [80, 81], thus providing an important role as a biomatrix
in pursuing the angiogenic effect.
In line with the current regenerative medicine trend, we recently demon-
strated that Amniotic Fluid Stem Cells (AFSC) can mediate the tissue repair
by recruiting host reparative cells [82] and that their secreted factors, con-
tained in conditioned media, can be responsible for a cell paracrine effect on
vessel growth [83]. We strongly believe that the increased blood flux achieved
by the administration of the AFSC soluble factors is a keystone of the whole
regenerative process, not only because of the increased nutrients perfusion,
but especially for the establishment of an “activated” regeneration niche. In
the present study, we embedded AFSC Conditioned Media (ACM) into a 15%
gelatin-membrane to topically deliver angiogenic growth factors and cytokines
4.2. MATERIAL AND METHODS 103
in a rat model of ischemic full-thick skin flap elevated in the epigastric region.
We studied the vascular perfusion rate, the vessel distribution and the survival
of ACM/membrane- and only membrane-treated flaps and demonstrated an
ACM-mediated recruitment of endothelial-like progenitors occurring only in
the subcutaneous tissues of ACM/membrane-treated flaps. We want to under-
line the benefits of a cell free therapy with no needs to differentiate uncommit-
ted stem cells into a specialized tissue both in terms of avoiding allo-rejection
and vi potential tumorigenic risks for the patient, and in terms of cost and
operating time savings.
4.2 Material and Methods
Cell Culture, Conditioned Media and Membrane Fabrication Hu-
man AFSC were supplied by the Cytogenetic Laboratory of Galliera Hospital
(Genoa, Italy) as normal karyotype amniocentesis samples from 15-17 weeks
pregnant women, after obtaining written informed consent. AFSC were iso-
lated as previously described [84, 83] Briefly, back-up cultures from a total of
20 donors were expanded in αMEM medium (Gibco, Milan, Italy) containing
15% ES-FBS, 1% glutamine and 1% penicillin/streptomycin (Gibco), supple-
mented with 18% Chang B and 2% Chang C (Irvine Scientific, Santa Ana,
CA, USA), at 37°C within a 5% CO2 atmosphere. Once confluent, cells were
pooled, labeled with CD117 MicroBeads (Milteyi Biotec, Bergisch Gladbach.
Germany) and immunoselected based on cKit expression on a Mini-MACS
apparatus (Miltenyi Biotec) following manifacturer instructions. Selected cells
were plated at clonal density (10/cm2) and about 7-10 days after seeding, clones
were isolated and replated and passaged few times in dishes with a larger di-
ameter. Two AFSC clonal lines, from the same primary culture and showing a
similar phenotype, were arbitrarily used at a culture passage between passages
6 and 10 in our experiments. Cultured cells were tested for the expression of
lineage specific surface e molecules in a Cyan ADP Cytofluorimeter (Beckman
Coulter) and the absence of hematopoietic markers together with the presence
104 CHAPTER 4. FILMS FOR BIOACTIVE MOLECULE RELEASE
of mesenchymal markers were confirmed (Supplementary Figure 1). Murine
monoclonal anti-human antibodies used for this study were: anti-CD117 (cKit)
PE-conjugated (clone A3C6E2, Miltenyi Biotec), anti-CD45 (TA218/12, IgM),
anti-CD31 (89D3, Ig2a) and anti-CD44 (T61/12, IgG1), kindly provided by M.
R. Zocchi (San Raffaele Scientific Institute), anti-CD90 (clone Thy-1A1, IgG2a
from R and D System Inc.), anti-CD146 (P1H12, IgG1 from BD PharMingen),
anti-SH2 (CD105, IgG1) and anti-SH3 (CD73, IgG2b) producing hybridoma,
purchased from the American Type Culture Collection (ATCC, Manassas, VA),
followed by the addition of anti-isotype specific goat anti-mouse (GAM) an-
tisera (Southern Biotechnology) conjugated with phycoerythrin (PE) (Invit-
rogen). Control samples were stained with isotype-matched irrelevant mAb
(Becton Dickinson) followed by anti-isotype specific GAM-PE. To obtain con-
ditioned media, eighty % confluent AFSC were plenty washed in PBS and
incubated in serum free αMEM for 16 hours [83]. AFSC conditioned me-
dia (ACM) were collected and stored in 5 milliliter aliquots equivalent to the
medium conditioned by 4 X 106 AFSC. This concentration (1 mL medium con-
ditioned by 800 000 AFSC during a 16 hour culture) was used for all in vivo
studies. Lyophilized gelatine film membranes (5 x 5 cm and 1.5 mm thick)
were prepared by casting from a solution of 15% by wt. type A gelatine (from
porcine skin, Sigma Aldrich, Milan, Italy) in water as follows. Briefly, a gela-
tine/water solution was prepared under gentle stirring at the temperature of
50°C for 1 hour, then cast into a polystyrene Petri dish kept at 23°C for 24
hours. Afterwards, the cast membrane was freeze-dried at -80°C for 72 hours.
Each membrane was regenerated before further use by its soaking with 5 ml
of ACM or saline as control (CTRL). Such a membrane is easy to handle, re-
sorbable within 24-48 h in vivo, it can entrap and slowly release proteins and
finally it is a useful delivering substrate suitable for the fascio-cutaneous flap
experiment protocol.
Fascio-cutaneous Flap Model and Treatment All experiments performed
on animals were approved by the local legislative committee in Vienna to the
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Ludwig Boltzmann Institute and all experimental procedures were consistent
with the Guide for the Care and Use of Laboratory Animals of the National
Institute of Health (Publication No. 85–23, revised 1996). Ten (five per group)
male Sprague Dawley rats weighing 300–350 g (Harlan– Winkelmann, Borchen,
Germany) were used to recreate the previously established epigastric flap model
[85]. The rats were anaesthetized with ketamine (100mg/kg BW) and xylazine
(10mg/kg BW). Briefly, abdominal skin of rats was depilated and a squared
fascio-cutaneous flap (approximately 7 X 7 cm) was elevated in a cranial to
caudal direction so that the flap was well detached from the abdominal muscu-
lar layer. Conditioned medium containing (ACM) or non containing (control
- CTRL) membranes were carefully positioned on the muscular layer (figure
4.1C). To render the flap half ischemic, the left or the right (according to a
randomization protocol) inferior epigastric neurovascular bundle was ligated
before the split of the epigastric pedicle into a medial and a lateral branch. To
avoid neighboring anastomoses, the entire flap was isolated from the surround-
ing tissues except for the contralateral inferior epigastric neurovascular pedicle
that remained pervious and perfused the rest of the flap. The flap was then
sutured back to its anatomical location. Animals were followed-up for 1 week,
afterwards they were sacrificed to take samples for Phistological and biological
studies.
Flap Perfusion and Survival These two parameters were evaluated by
two independent observers on three different vertical zones (Vital, Border, Is-
chemic; 2.5 X 7 cm/each) of the flap (figure 4.1D) at different times: before
operation (Pre-OP), immediately after operation (Post-OP) and 1, 2, 3 and 7
days after surgery. To evaluate flap perfusion, we used the LDI (Moor Instru-
ments Ltd., Devon, UK) system with a low-intensity (2 mW) laser light beam
(wavelength 632.8 nm). The skin surface of supine positioned, anaesthetized
rats was scanned at a standardized working distance of 20 cm. Blood flow
through the flap was documented as 2D color-coded image (setting of scan
modus 10 ms/pixel with resolution at 256X256 pixels). Results are expressed
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as fold increase/decrease of perfusion units (PU) respect to the pre-operative
baseline (=1), through the time and for each sector of the flap. The flap sur-
vival, as percentage (%) of necrosis, was calculated dividing the flap necrotic
area to the entire flap area, multiplied by 100. Flap areas were photo-imaged by
MoorTM at standardized conditions of light, distance, and magnification, and
analyzed with ImageJ 1.44 software (National Institutes of Health, Bethesda,
Maryland, US). To be considered necrotic, an area should have macroscopically
visible brown- to black-colored tissue accompanied by loss of elasticity. As a
quality control, areas identified as necrotic were checked for having a Laser
Doppler pixel distribution curves ranging between 50-70 over a scale 0-255.
Histological Analysis Full-thickness skin samples, proximal to the necrotic
area of flaps, were excised from each animal after euthanasia on day 7 and over
night fixed in buffered neutral formalin 10% (Sigma), dehydrated in ethanol
70% (2 h), ethanol 80% (2 h), ethanol 96% (2 h), absolute ethanol (2 h), cleared
in xylol and embedded in paraffin into an upright position. Fascio-cutaneous
cross sections were stained with Mallory’s trichrome (Bioptica, Milan, Italy)
in order to evaluate the inflammatory infiltrates (masses of red nuclei), the
vascularization of subcutaneous plexus (red blood cells in gold yellow), the
thickness of superficial necrotic layers (orange - red) and the organization of
cutaneous structures (glands in pale pink and collagen fibers in deep blue).
Density of subdermal plexus vessels with a diameter≥ 40 µm vi was determined
on five random fields (400 X magnification), on six 7 mm thick-cross sections
for each sample. Thickness of cutaneous dead layers was measured along 3mm
of each section using the Axiovision Rel 4.4 software and distribution curves
were generated for each group of treatment.
Recruitment Studies and Progenitors Isolation Recruitment studies
and progenitor isolation were performed on 10 rats. To study the recruitment
of progenitor cells into the injured/repaired site, we excised the piece of flap
(2 X 1 cm) showed in figure 4.1E. Briefly, we considered a square delimited by
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the medial line of the whole flap area and the outlining border of the necrotic
area. This squared piece corresponds to the healing region of the flap. In fact,
since after the ligation of one epigastric bundle just half flap is perfused, the
medial line can be considered the “growth plate” of new vessels that from a
pre-existing vasculature move toward an ischemic region. That full-thickness
skin piece was then sliced according to depth [86]. The upper part (from the
surface to a 0.15-0.20 mm depth) contained the epidermis and the papillary
dermis and was discarded. The rest of the skin, corresponding to the reticular
dermis, hypodermis and fascia, being the most vascularised part of the skin,
was used in our studies to isolate and identify endothelial progenitors. Samples
were minced, washed in HBSS/30 mM HEPES (Euroclone, Milan, Italy) plus
penicillin and streptomycin, digested in 0.25% trypsin (Gibco) and 200 U/mL
type 2 Collagenase (Biochrom, AG Berlin, Germany) for 60 minutes in 37°C
water bath and finally passed through a 70 µm nylon mesh to obtain a single
cell suspension. Cells were centrifuged at 300 X g and the lipid phase was
removed from the top and discarded. Freshly isolated cells were either ana-
lyzed with a Cyan ADP cytofluorimeter (Beckman-Coulter, Brea CA, USA)
for the presence of different cell surface antigen markers or plated at a den-
sity of 8,000 cells/cm2 onto fibronectin-coated Petri dishes (BD Biosciences,
Erembodegem, Belgium). This pre-plating step was introduced to separate
cells of the stromal-vascular fraction (SVF) from the less adherent endothelial
progenitors. Forty eight hours after plating, nonadherent suspended cells were
collected and re-plated (25 cells/cm2) onto fibronectin-coated plates in order to
assess the presence of clonogenic progenitors [87]. We chose a fibronectin coat-
ing in order to provide the endothelial-lineage cells with a matrix suitable for
their attachment and expansion. Medium (DMEM/F12_10% FBS, without
any supplemental Growth Factors) was changed every three days. Seven days
after the replating, colonies were fixed in 10% formalin and stained for the spe-
cific endothelial marker Von Willebrand Factors (Rabbit polyclonal anti-vWF
by DAKO, Glostrup, Denmark and TRITC-conjugated goat anti-rabbit IgG
by Jackson Immunoresearch Labs, Baltimore Pike West Grove, PA, USA).
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Suppliers Antibodies used for the cytofluorimetric analysis were: APC-
conjugated anti-CD31 (clone 390), PE-conjugated anti-CD34 (clone RAM34)
by E Bioscience, San Diego, CA, USA, and PE-conjugated anti-Flk1/VEGFR2
(clone Avas 12a1) by BD PharMingen San Diego, CA, USA. Control samples
were stained with isotype-matched irrelevant mAb. Data were analyzed us-
ing the Summit 4.3.1 computer program and are reported as Log fluorescence
intensity vs. number of cells.
Statistical Analysis All values are expressed as mean ± standard error.
Statistical differences between groups were assessed by the use of unpaired
t-test and Mann Whitney U test. We considered a p-value < 0.05 to be signif-
icant.
4.3 Results
Vascularization of flap sectors Blood perfusion through the flap was
evaluated at LDI by measuring the perfusion units (PU) average of each sector
and was expressed as fold increase/decrease respect to the preoperative baseline
assumed to be equal to 1 (figure 4.2B). As a confirmation of the correctly
executed ligation of the epigastric neurovascular bundle, in the immediate Post-
OP the Vital zone of the flap was perfused as before the operation, while in the
Border zone and even more in the Ischemic zone the perfusion was strongly
decreased. In the Vital zone the perfusion was doubled starting from Day
1 and remained steady through the whole week without significant differences
between the control and the treated animal groups. This increased perfusion in
the zone of the flap vascularized by the not ligated artery (Vital zone) must be
considered compensative of the absence of vascularization in the flap ischemic
counterpart. In the Border zone a similar hyper-reaction occurred at Day 1,
but the increasing trend of the perfusion was mantained through the week
only in the ACM animal group . At Day 7 the Vital and the Border parts
of the CTRL-treated flaps showed a reduced hyper-perfusion effect, while the
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same parts of the ACM-treated flaps continued to show an increased perfusion
effect. We conclude that the observed effect was treatment-dependent rather
than a physiological response of the body consequent to the ongoing injury. In
the Ischemic zone, the CTRL membrane never recovered the initial perfusion
(baseline level), while in the same ACM- treated zone the perfusion level at
Day 7 was 50% higher than the initial baseline. We concluded that, although
the simple injury (ligation of the epigastric bundle) triggered an angiogenic
response, this was not sufficient to re-vascularize an ischemic area. On the
contrary, the ACM treatment mediated the growth and the sprouting of new
vessels toward the ischemic regions.
Necrosis development through the flap We measured the necrotic areas
developed through the flap and calculated the percentage (%) of necrosis to the
entire flap area. Necrosis started to be evident in the ischemic (ligated) part
at Day 1 for the flaps treated with the CTRL membrane and at Day 2 for the
ACM-treated flaps (figure 4.3). Once started, necrosis spread through the flap
toward the midline and the CTRL membrane failed to stop its development.
The survival of the flap is linked to the blood supply and, looking at the per-
fusion data (figure 4.2) of the ischemic zone, one can notice that in the CTRL
group the perfusion increased very slowly during the week, never getting to
the baseline. On the contrary, in the ACM group the ischemic zone suffered
a less severe blood supply deficiency during the first 3 days post surgery and
recovered a complete perfusion at Re Day 7 (figure 4.2). Indeed, in the CTRL
group, where the ischemic zone was never recovered, the necrosis % was pro-
gressively increasing, while in the ACM group, where vessels finally crossed
the ischemic part, at Day 7 the necrosis % was significantly lower (figure 4.3).
Histological Analysis of cutaneous and subcutaneous structures We
excised full-thickness skin samples proximally to the necrotic area of flaps.
Looking at the cutaneous structures of the CTRL group (figure 4.4A, up-
per right panel), it is of notice the thickness of the dead upper epidermal
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Figure 4.1: Experimental Procedure: Most important passages of the experi-
mental procedure. (A) The rat abdomen is depilated and the flap perimeter (7
X 7 cm) is outlined. (B) The epigastric bundle is ligated. (C) The membrane
is positioned under the elevated skin flap; (D) Flaps are sutured back and di-
vided into the three sectors (Ischemic, Border, Vital), based on the proximity
to the ligated bundle. (E) The red line indicates the flap area excised after
7days and considered for the recruitment studies and the progenitor isolation;
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Figure 4.2: Flap Perfusion: (A) Laser Doppler Imaging of flaps before (PreOP),
immediately after the Operation (PostOP) and at different times after ligation
of the epigastric bundle for the ACM group (upper panel) and the CTRL
group (bottom panel); (B) Perfusion is measured as fold increase/decrease
of the perfusion respect to the Pre-operative baseline (assumed to be =1) at
different times after ligation of the epigastric bundle and for each sector of the
flap. *p-value < 0.05
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Figure 4.3: Necrosis development: Histograms represent the percentage of
developed necrosis throughout the whole flap area immediately after the op-
eration (PostOP) and at different times after ligation of the epigastric bundle.
Photos represent a macroscopic view of the ACM and CTRL-treated flap at
day 7 post surgery . * p-value < 0.05
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Figure 4.4: Histological analysis: (A) Histology of cutaneous (upper panels)
and subcutaneous (lower panels) tissues of ACM-treated (right panels) and
CTRL-treated (left panels) flaps. Mallory’s trichrome staining. Dashed lines
indicate thickness of the superficial necrotic layer. Arrows point to vessels
of the subdermal plexus. Scale Bar 200µm. Photos by an Axiovert 200M
microscope (Zeiss). (B) Density of subdermal vessels is indicated in histograms.
(C) Distribution curves of cutaneous dead layer thickness (black curve for ACM
group, grey curve for the CTRL group). * p-value < 0.01
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Figure 4.5: Vascular Progenitor Recruitment: Cytofluorimetric analysis of cells
extracted from the ACM-treated (upper panel) and the CTRL-treated (lower
panel) flaps. Histograms on the left show single staining analysis for the mark-
ers CD31, VEGFR2, CD34 (grey histograms are the isotype-matched mAb
used as control). Dot charts on the right show double staining analysis for
CD31/VEGFR2 and CD31/CD34 positive cells. Percentage of positive cells
and mean fluorescence intensity are shown as well. Shown results are represen-
tative of independent determinations performed on cells recovered from each
animal. Data analysis with Summit 4.3.1 software.
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Figure 4.6: Isolation of EPCs: (A) Cells extracted from ACM and CTRL-
treated flaps after 48 hours of culture (100 X magnification); (B) CFU formed
after plating the floating fraction at a clonogenic density (200 X magnification);
(C) vWF-staining of two different CFU obtained from cells extracted from
the ACM-treated flaps (200 X magnification). Photos by an Axiovert 200M
microscope (Zeiss).
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Figure 4.7: Human AFSC Cytofluorimetric Characterization: Surface expres-
sion of the indicated molecules. Human AFSCs were stained with mAbs to dif-
ferent markers (black histograms). In each panel it is shown (grey histogram)
the isotype matched mAb used as control. Results are expressed as Log fluo-
rescence intensity arbitrary units (a.u.) vs number of cells. Data analysis with
Summit 4.3.1 software.
layer (orange), the disorganization of the collagen fibers (blue) in the papil-
lary layer and the dermal glands (pale pink) that appears less numerous and
atrophied. Instead, the ACM-treated group (figure 4.4A, upper left panel),
showed some detached dead stratum corneum, a normal epithelialization of
the stratum spinosum and basale, and a correct arrangement of the collagen
fibers and glands in the underlying dermis. In the subcutaneous tissues (figure
4.4A, lower panel) where hypoderm and underlying fascia are visible, the vessel
density was about five folds increased in the ACM group respect to the CTRL
group (figure 4.4B), as well as the presence of inflammatory infiltrates. The
high vascularization, histologically detected in the ACM-treated subcutis, well
explain the survival of the upper structures of the skin. Thickness distribu-
tion curves of dead cutaneous layers (figure 4.4C) are right side-located in the
CTRL group because necrotic layers are thicker in not- treated rats, ranging
from 300 to 700 µm. Instead, necrotic layers of ACM group have a distribution
curve averaged on 35-100 µm (50% of layers).
Recruitment of endothelial progenitors The flap area we chose for
these studies is showed in figure 4.1E and described in Materials and Methods.
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Subcutaneous tissues were excised from each animal and digested to obtain a
single cell suspension (cells freshly isolated). Cells suspensions were analyzed
at the cytofluorimeter for the presence of endothelial cell (EC) and endothelial
progenitor cell (EPC) markers [88, 89, 90], such as CD31, CD34 and Flk1
(VEGFR2) (figure 4.5). Cells isolated from ACM-treated flaps included about
10% of CD31, 23% of VEGFR2 and 15% of CD34 positive cells. Furthermore,
a double positive population for CD31/CD34 (0.9% of the total amount of
extracted cells) and a double positive population for CD31/VEGFR2 (3.4% of
the total) were isolated from the ACM group.
While ACM contains soluble factors capable to chemoattract circulating
progenitors and mediate the blood vessels growth, the not treated ischemia
alone was not able to recruits EPCs in the subcutaneous tissues of the flap.
In fact, cells isolated from the flaps of the CTRL group were negative for
the markers CD31 and CD34, and only 15% of them expressed the VEGFR2.
When we searched for double positive cells, only 0.2% of CD31+/VEGFR2+
cells and 0.1% of CD31+/CD34+ cells were observed.
Isolation of endothelial progenitors Cells derived from the subcutaneous
tissues of ischemic flaps were cultured with a two steps procedure. First cells
were pre-plated onto fibronectin-coated dishes for 48 h (figure 4.6A) in order to
separate adherent from floating cells. Adherent cells extracted from the CTRL
group grew slowly, while cells from ACM group got the 70% of confluence in
48 h and presented both polygonal and spindle morphology (figure 4.6A). The
nonadherent cells were re-plated at a clonogenic density (25 cells/cm2) onto
fibronectin-coated dishes. After 7 days of culture colonies were analyzed (figure
4.6B). From ACM group we isolated several colonies (1.7 er CFU/cm2) with
the typical cobblestone morphology surrounded by radiating thin cells and
characterized by a central cluster of rounded cells. These clusters were found
positive for the vWF (figure 4.6C), confirming their endothelial nature. We
did not obtain colonies from the CTRL group in agreement with the observed
absence of double positive progenitors in the freshly isolated subcutaneous cells
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from this animal group.
4.4 Discussion
Ischemia of the operated tissues is a very common and difficult to handle com-
plication of many surgeries. Necrosis of tissues occurs secondary to an early
reperfusion injury or a prolonged absence of blood supply. The animal model
we chose provides a very serious (half flap-extended and 1 week-protracted) is-
chemic damage, since the vascularization of the flap is prevented by the chronic
epigastric artery ligation and the complete elevation of the whole flap area.
Several studies have used angiogenic growth factors [91], in local or systemic
administration [92], as recombinant proteins or by gene delivery [93], to pursue
a therapeutic angiogenesis of ischemic flaps. We previously demonstrated [83]
that the AFSC secretome is responsible for the paracrine vascularizing effect
that these cells showed in vivo. We described the conditioned media of human
AFSC as a potent cocktail of combined chemokines (such as MCP-1, IL-8,
SDF-1α,) and growth factors (such as VEGF, TGFβ), synergically promot-
ing the neovascularization of ischemic tissues. Here we used 5 mL of 16 hour
conditioned media (each mL from 800 000 AFSC) for each 25 cm2 gelatine
membrane (secretome from 30 000 AFSC per cm2). This low ACM concen-
tration was demonstrated to be effective in this formulation. The membrane
we used, offers a good solid support for the local delivery of the ACM at the
injury site. This approach was useful to potentiate [79] and at the same time
topically limit the neovascularization, thus avoiding clinical concerns linked to
a systemic administration of angiogenic growth factors, such as the targeting
of non specific tissues or, on the other hand, the blood diluting effect and the
reduced half-life of circulating proteins.
The support membrane that we chose, made of gelatine, i) is a biodegrad-
able, biocompatible and nonimmunogenic product, suitable for many medi-
cal applications; ii) its hydrophilic nature enables absorption of ACM; iii) in
the adopted formulation it can undergo a gel/sol transition at body tempera-
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ture thus releasing proteins in a controlled way. The gelatin membrane alone,
soaked with saline, was implanted in rats of the CTRL group, where no recov-
ery of the ischemic sector of the flap occurred. Postnatal growth of new vessels
is activated during pathological conditions, such as wound healing, tumorige-
nesis and tissue ischemia [94]. In our CTRL group the ischemic injury per
se triggered a neovascularization, as the compensative hyper-perfusion effect
in the Vital and Border zones showed, nevertheless this was not sufficient to
re-establish a normo-perfusion in the Ischemic zone within the first week. The
initial baseline level of perfusion was never achieved, the subsequent necrosis
reached the 18% of the whole flap area with peaks of 23%, and no progeni-
tors were detected (cytofluorimetric analisys) or isolated (CFU analysis) from
the ischemic subcutis. The post-injury vascularization can be enhanced by
the administration of growth factors and cytokines [76] that recruit EPC into
the injury site, thus accelerating the wound healing. In the ACM group, at
Day 7, the ischemic area was re-vascularized with a perfusion level 50% higher
than the initial baseline and, as a consequence, presented a less developed
necrosis respect to the CTRL group. The histology of ACM-treated flaps re-
vealed a thin dead stratum corneum, a normal arrangement of the epidermal
and dermal structures and a high density of vessels in the subcutaneous tis-
sues. More important, we showed that ACM recruited CD31+/VEGFR2+ and
CD31+/CD34+ cells into the ischemic subcutaneous tissues, where growth
and sprouting of new vessels occurred. Since subcutaneous tissues contain
blood, adipose cells and other derivatives of mesodermal origin, we used a
double staining analysis for the quantification of endothelial progenitors from
the freshly isolated cell population. In fact, CD31 cannot be considered a
specific marker of endothelial cells, since it is expressed also by circulating
monocytes [95]. Similarly, CD34 cannot be considered a solely marker of EPC
since CD34-positive cells can be abundantly isolated also from the total non-
endothelial population within the stromal-vascular fraction (SVF) of adipose
tissues [96]. Even the VEGFR2 is not a unique marker for hematovascular
lineage cells, since it is expressed also by developing and mature mesoderm
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derivatives [97]. We found that out of the 23% VEGFR2 positive cells and
the 15% CD34 positive cells extracted from the ACM-treated flap, 3.4% were
CD31/VEGFR2 double positive and 0.91% were CD31/CD34 double positive.
To confirm the ACM-mediated recruitment of endothelial progenitor cells, we
identified vWF-positive cell clones derived from the free floating cell fraction
obtained from the digestion of subcutaneous tissues. Given the extraction of
a high percentage of CD34 single positive and VEGFR2 single positive cells
from subcutaneous tissues of ACM group, together with the isolation of a
high proliferative SVF, one could speculate that the ACM also stimulated
stem/progenitor cells residing in the subdermal adipose tissue and dermis [98].
Many studies have demonstrated that a variety of growth factors and cytokines
are involved in the cutaneous wound healing; IL-6 is necessary for tissue gran-
ulation, VEGF for the wound angiogenesis, TGF-β for the reepithelialisation.
AFSC conditioned media contain these growth factors [83] together with other
soluble factors, such as chemokines (IL-8, MCP-1, SDF-1α) responsible for the
migration of inflammatory cells and for the mobilization, homing and incorpo-
ration of endothelial progenitors into the vasculature [99]. Again, since AFSC
secrete the mentioned growth factors and chemokines, as our and other groups
have demonstrated [100, 101, 102, 83, 103, 104][100, 101, 102, 83, 103, 104],
we hypothesize that the endogenous repair triggered by the AFSC secretome
could involve both the recruitment of EPC and the activation of local niches.
4.5 Conclusions
AFSC conditioned media loaded in a gelatine hydrogel, as a cocktail of “navi-
gation cues and niche signals” [105], are effective, safe, simple and reproducible
to formulate, convenient, easy to deliver, being good candidate for a transla-
tional treatment that could be: i) in situ-directed; ii) based on the activation
of endogenous mechanisms of repair; iii) cell-free, thus avoiding the ex vivo
manipulation of autologous or heterologous cells.
Chapter 5
Perspective on anti-adhesion
applications
5.1 Introduction
During the water absorption test (section 2.3.4), samples of gelatine gels were
prepared with PRP instead of water. Despite similarities in the kinetic of ab-
sorption, the resistance of these samples to the temperature was clear, there-
fore additional test followed in collaboration with the University of Genova.
The purpose was to discover the resistance of PRP loaded gelatine gels when
surgically implanted in-vivo.
5.2 Materials and Methods
Three different gelatine gel samples were compared in order to study the in-
fluence of PRP in gelatine hydrogels on the kinetic of in-vivo resorption.
Sample 1 was prepared as described in section 2.2.1, step 5, and rehydrated
with water.
Also sample 2 was prepared following the same procedure used before, but,
instead of using water, it was rehydrated by soaking in PRP for 2 hours at room
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temperature on an orbital shaker. The obtained PRP gel was then frozen at
-80 °C for at least 16 hours, and freeze-dried again for 15 hours.
Sample 3 was prepared dissolving gelatine powder in PRP at 37 °C, at a
15% concentration, under constant stirring for 1 hour; the solution was then
cast into a petri dish and left for 1 hour at room temperature to allow gelation
to take place. Successively the hydrogel was frozen at -80 °C, and freeze-dried
as already described (section 2.2.1, step 5).
After freeze drying procedure, all the three samples were sterilized by γ-
radiation (0.1 Gy) and rehydrated with sterile water.
Gels where successively implanted subcutaneously in six different CD-1
mice, weighing 20 - 25 g. Each mouse was implanted with every all the 3
samples of gelatine previously described (gelatine, PRP-loaded gelatine, and
gelatine prepared using PRP instead of water).
The implanted samples were retrieved after 6 hours, 24 hours and 7 days.
The resorption of the membranes was evaluated by visual inspection.
5.3 Results and Discussion
Three different samples of gelatine gels, normal and loaded with platelet rich
plasma (PRP), were prepared and implanted as described in section 5.2 and
compared to study the influence of the PRP on the gelatine gel resorption
kinetic in-vivo.
Results 6 hours after the implantation, all the gels were still present and in
sufficiently good conditions (figure 5.1), no evident degradation occurred.
At the successive check, 24 hours after implantation, some degree of degra-
dation and partial resorption were evident on all the samples (figure 5.2). In
the case of the PRP containing hydrogels (2 and 3), corners and surface were
smoother, indicating some erosion but no degradation of the “bulk”. On the
contrary on the pure gelatine gel (1) it was possible to notice cracks passing
through the material, and sharp borders, indicating detachment of fragments:
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Figure 5.1: Gelatine gel samples after 6 hours from the implantation
Figure 5.2: Gelatine gel samples after 24 hours from the implantation
in this case the degradation was much quicker.
7 days after implantation (figure 5.3) samples 1 and 2 were completely re-
sorbed while sample 3 was still present, indicating a strong interaction between
PRP and gelatine specially when they PRP is added to the liquid suspension
of gelatine.
Conclusions This preliminary in-vivo degradation test allowed to discover
the interesting interaction between gelatine and PRP. Appropriately modifying
the quantity of PRP used to prepare the membrane it was possible to tailor
the in-vivo degradation rate.
Gelatine is known to be biodegraded by several enzymes [106]. Therefore
an appropriate tuning of the in-vivo degradation rate would allow to have a
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Figure 5.3: PRP-Gelatine sample after 7 days. Gelatine and “PRP Loaded
Gelatine” were completely resorbed
good material to employ as barrier to prevent surgical adhesions, and to stay
in place for the time needed. Successively it dissolves and degrades rapidly
without hard debrises production.
Chapter 6
Final Remarks
This thesis investigated the production of uncross-linked gelatine hydrogels.
Different applications were analyzed in order to exploit the gel-sol transition
of these gels.
Gelatine hydrogel based patches, with melting temperature in the range
36 °C - 39 °C, were obtained by solution casting. These gels were dried to
allow long (months to years) shelf-life, retaining their distinctive property,
that is the ability to be rehydrated forming a hydrogel when needed and to be
melted / dissolved at a biologically tolerable temperature. The use of these
patches for wound and burn healing would help keeping a moist environment
on the injury allowing a better healing process to occur. After the treatment
or before any medication, the gelatine patch was demonstrated to be easily
removable by washing with warm sterile water, allowing a gentle detachment
which preserves the new formed tissue.
In order to culture cell sheets on the gelatine gel substrate, it was developed
a novel cell culture protocol. By using this procedure, it was possible to realize
confluent fibroblast layers. These layers, cultured on the gelatine surface, were
demonstrated to be integrally transferable to different surfaces, without the
use of any proteolytic enzyme, simply by exploiting the gelatine melting at
body temperature (37 °C). This cell sheet culture substrate, unlike traditional
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PNIPAAm grafted TCPs, can be implanted in-vivo where it can degrade /
dissolve with no need for removal. Moreover, gelatine hydrogels are inexpensive
and much easier to prepare. Additionally, the possibility to obtain 3D cell
structures in these hydrogels was demonstrated.
Finally, uncross-linked gelatine hydrogel, loaded with pro-angiogenic fac-
tors, were tested in-vivo on a model of ischemic fasciocutaneous flap, demon-
strating the possibility to use these bioresorbable hydrogels as depot for situa-
tions which require an in-situ rapid release (less than one week). Additionally,
gelatine gels loaded with PRP showed an in-vivo degradation rate which sug-
gests their use as separator to avoid surgical adhesions.
Concluding, uncross-linked gelatine hydrogels showed interesting properties
and versatility for many biomedical applications. Their main property, the
ability to melt at body temperature, is still almost completely unexploited in
the medical field. For this reason the work described in this thesis was protected
by two patent deposits: EP 11 183 232 “Therapeutic use of gelatin hydrogels
with a gel-sol transition at body temperature” and EP 11 183 233 “Medical
uses of lyophilized polymeric membranes containing blood derivatives”.
Appendix A
Materials
• Gelatine Powder: provided by Sigma-Aldrich, Gelatin from porcine skin,
Type A - G8150 batch n.:059K0019
• Sterile Water: provided by Euroclone(ECM0970D).
• D-PBS without Calcium and Magnesium: provided by Euroclone (ECB4004L).
• Trypsin 0.05% - EDTA 0.02% in PBS: provided by Euroclone (ECB3052D).
• Fibroblasts. Human Fetal Lung Fibroblast Line (MRC-5): provided by
Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Ro-
magna "Bruno Ubertini" - Brescia
• The Culture Medium Composition used for cell culture is described in
table A.1.
• Phase Contrast and Fluorescence Microscope: Zeiss Axiovert 25
• Optical Microscope: Zeiss Axiotech
• Laser Confocal Microscope: Nikon A1
• Ultra-sonication device: Hielscher UP400S
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NAME SUPPLIER CAT. N. CONC.
Minimum Essential Medium Invitrogen 21090022
Fetal Bovine Serum (FBS) Gibco 10106 1:10 FBS:MEM
Sodium Pyruvate Euroclone ECM0542D 1 mM
L-Glutamine Euroclone ECB3000D 2 mM
Non Essential Amino Acids Gibco 11140 0.1 mM
Antibiotic Antimycotic Gibco 15240 1:10000 AA-MEM
Table A.1: MRC-5 Culture Medium Composition
• Mechanical Testing Machine: Instron 4502
• Dynamic Scanning Calorimetry, Mettler DSC 30
Appendix B
Publications
Patents
• EP 11 183 232 - THERAPEUTIC USE OF GELATIN HYDROGELS
WITH AGEL-SOL TRANSITION AT BODY TEMPERATURE - Chris-
tian Lorandi, Claudio Migliaresi, Antonella Motta, Ranieri Cancedda,
Maddalena Mastrogiacomo, Anita Muraglia
• EP 11 183 233 - MEDICAL USES OF LYOPHILIZED POLYMERIC
MEMBRANES CONTAINING BLOOD DERIVATIVES - Christian Lo-
randi, Claudio Migliaresi, Antonella Motta, Ranieri Cancedda, Mad-
dalena Mastrogiacomo, Anita Muraglia
Articles
• Pro-angiogenic soluble factors from Amniotic Fluid Stem Cells mediate
the recruitment of endothelial progenitors in a model of ischemic fascio-
cutaneous flap. - Teodelinda Mirabella, Joachim Hartinger, Christian
Lorandi, Chiara Gentili, Martijn van Griensven, and Ranieri Cancedda.
Stem Cells and Development. Ahead of print. doi:10.1089/scd.2011.0639.
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Congresses
• Natural polymer gels for biomedical uses - Claudio Migliaresi, Michael
Floren, Christian Lorandi, Michele Preghenella and Antonella Motta -
ACS Meeting, San Diego, March 2012
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